[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 3428
1. Betti R, Radaelli G, Bombonato C, Crosti C, Cerri A, Menni S: Anatomic location of Basal cell carcinomas may favor certain histologic subtypes. J Cutan Med Surg; 2010 Nov-Dec;14(6):298-302
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anatomic location of Basal cell carcinomas may favor certain histologic subtypes.
  • BACKGROUND: Differences in age, site, and subtype exist in basal cell carcinoma (BCC).
  • OBJECTIVE: To evaluate whether an independent association exists between the anatomic location and the histologic subtype of BCC.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Head and Neck Neoplasms / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21084023.001).
  • [ISSN] 1203-4754
  • [Journal-full-title] Journal of cutaneous medicine and surgery
  • [ISO-abbreviation] J Cutan Med Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Kritz-Silverstein D, Schneider DL, Sandwell J: Breast cancer and bone mass in older women: is bone density prescreening for mammography useful? Osteoporos Int; 2006;17(8):1196-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Bone Density. Breast Neoplasms / etiology. Mammography

  • Genetic Alliance. consumer health - Bone Cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Bone Density.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Mammography.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bone. 2003 Mar;32(3):211-6 [12667548.001]
  • [Cites] Cancer Causes Control. 1994 Nov;5(6):523-8 [7827239.001]
  • [Cites] Am J Epidemiol. 1990 Nov;132(5):877-83 [2239902.001]
  • [Cites] Environ Health Perspect. 1997 Apr;105 Suppl 3:583-5 [9167999.001]
  • [Cites] JAMA. 1999 Dec 8;282(22):2156-63 [10591338.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Apr;80(4):1118-23 [7714079.001]
  • [Cites] J Natl Cancer Inst. 1998 Jun 3;90(11):814-23 [9625169.001]
  • [Cites] Am J Epidemiol. 2001 Jun 1;153(11):1071-8 [11390325.001]
  • [Cites] Endocr Rev. 1994 Jun;15(3):275-300 [8076582.001]
  • [Cites] J Natl Cancer Inst. 1995 Feb 1;87(3):190-7 [7707406.001]
  • [Cites] Ann Intern Med. 1997 Dec 1;127(11):955-65 [9412300.001]
  • [Cites] World Health Organ Tech Rep Ser. 1994;843:1-129 [7941614.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):533-9 [8827358.001]
  • [Cites] Science. 1988 Jul 1;241(4861):84-6 [3388021.001]
  • [Cites] JAMA. 1996 Nov 6;276(17):1404-8 [8892715.001]
  • [Cites] J Natl Cancer Inst. 2001 Jun 20;93(12):930-6 [11416114.001]
  • [Cites] Bone Miner. 1993 Feb;20(2):141-9 [8453330.001]
  • [Cites] J Clin Epidemiol. 2001 Apr;54(4):417-22 [11297892.001]
  • [Cites] Environ Health Perspect. 1997 Apr;105 Suppl 3:593-9 [9168001.001]
  • [Cites] J Chronic Dis. 1987;40(2):105-13 [3818863.001]
  • [Cites] J Am Acad Nurse Pract. 2001 Jun;13(6):276-84 [11930870.001]
  • [Cites] N Engl J Med. 1997 Feb 27;336(9):611-7 [9032046.001]
  • [Cites] Eur J Cancer. 1998 Jul;34(8):1163-74 [9849474.001]
  • [Cites] JAMA. 1999 Jun 16;281(23):2189-97 [10376571.001]
  • (PMID = 16699738.001).
  • [ISSN] 0937-941X
  • [Journal-full-title] Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
  • [ISO-abbreviation] Osteoporos Int
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / M01 RR00827
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 1406-16-2 / Vitamin D
  •  go-up   go-down


3. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE: Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res; 2005;7(1):R1-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Viruses including Epstein-Barr virus (EBV), a human equivalent of murine mammary tumour virus (MMTV) and human papillomavirus (HPV) have been implicated in the aetiology of human breast cancer.
  • We report the presence of HPV DNA sequences in areolar tissue and tumour tissue samples from female patients with breast carcinoma.
  • METHODS: Polymerase chain reaction (PCR) was undertaken to amplify HPV types in areolar and tumour tissue from breast cancer cases.
  • In situ hybridisation supported the PCR findings and localised the virus in nipple, areolar and tumour tissue.
  • [MeSH-major] Breast Neoplasms / virology. Carcinoma / virology. Nipples / virology. Papillomaviridae / genetics. Papillomaviridae / pathogenicity

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Res Pract. 1992 Apr;188(3):384-6 [1320761.001]
  • [Cites] J Natl Cancer Inst. 2001 Jun 6;93(11):824-42 [11390532.001]
  • [Cites] Cancer Res. 1992 Nov 1;52(21):5872-8 [1327518.001]
  • [Cites] EMBO J. 1993 May;12(5):1847-52 [8387914.001]
  • [Cites] J Gen Virol. 1994 May;75 ( Pt 5):1157-62 [8176376.001]
  • [Cites] Curr Top Microbiol Immunol. 1994;186:1-12 [8205835.001]
  • [Cites] J Dermatol. 1994 Oct;21(10):709-15 [7798425.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7829-33 [7644500.001]
  • [Cites] Virology. 1996 Jun 1;220(1):1-9 [8659100.001]
  • [Cites] Breast Cancer Res Treat. 1996;39(2):197-202 [8872328.001]
  • [Cites] Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78 [8876633.001]
  • [Cites] Breast Cancer Res Treat. 1996;41(1):51-7 [8932876.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):961-5 [8959317.001]
  • [Cites] J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62 [9049358.001]
  • [Cites] Int J Cancer. 1997 Nov 4;73(3):356-61 [9359482.001]
  • [Cites] Mol Cell Biol. 1998 Apr;18(4):1793-801 [9528751.001]
  • [Cites] J Virol. 2001 Dec;75(23):11791-802 [11689660.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] J Hum Virol. 2001 Nov-Dec;4(6):329-34 [12082399.001]
  • [Cites] Int J Cancer. 2002 Jul 10;100(2):214-9 [12115572.001]
  • [Cites] J Virol. 2002 Oct;76(20):10559-68 [12239337.001]
  • [Cites] Lancet. 2002 Oct 5;360(9339):1044-9 [12383984.001]
  • [Cites] Int J Cancer. 2002 Nov 20;102(3):304-7 [12397656.001]
  • [Cites] Br J Cancer. 2002 Nov 18;87(11):1234-45 [12439712.001]
  • [Cites] Cancer. 2002 Dec 15;95(12):2571-6 [12467072.001]
  • [Cites] J Natl Cancer Inst. 2002 Dec 18;94(24):1832-6 [12488476.001]
  • [Cites] J Virol. 2003 Jan;77(2):1551-63 [12502868.001]
  • [Cites] J Med Virol. 2004 Mar;72(3):473-7 [14748072.001]
  • [Cites] Int J Cancer. 2004 Mar 20;109(2):253-8 [14750177.001]
  • [Cites] Breast Cancer Res Treat. 2004 Mar;84(2):131-7 [14999143.001]
  • [Cites] Int J Cancer. 1982 Feb 15;29(2):143-6 [6277807.001]
  • [Cites] Int J Cancer. 1985 Nov 15;36(5):575-8 [2997044.001]
  • [Cites] J Virol. 1986 Jan;57(1):353-6 [3001357.001]
  • [Cites] J Virol. 1986 Jun;58(3):963-6 [3009899.001]
  • [Cites] Cancer. 1987 Oct 15;60(8):1832-5 [2820563.001]
  • [Cites] Virology. 1988 Jul;165(1):225-33 [2838960.001]
  • [Cites] Virology. 1989 Nov;173(1):284-90 [2554574.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(1):463-7 [2153303.001]
  • [Cites] Br J Dermatol. 1990 Jun;122(6):757-62 [2164414.001]
  • [Cites] Am J Clin Pathol. 1991 Feb;95(2):117-24 [1846996.001]
  • [Cites] Virology. 1991 Nov;185(1):484-7 [1656601.001]
  • [Cites] Br J Cancer. 1992 Jun;65(6):891-4 [1319728.001]
  • [Cites] J Invest Dermatol. 1998 May;110(5):752-5 [9579540.001]
  • [Cites] Laryngoscope. 1998 May;108(5):735-40 [9591556.001]
  • [Cites] Biomed Pharmacother. 1998;52(1):26-33 [9755792.001]
  • [Cites] Int J Cancer. 1999 Mar 1;80(5):681-4 [10048966.001]
  • [Cites] Int J Cancer. 1999 Apr 12;81(2):225-8 [10188723.001]
  • [Cites] Breast Cancer Res Treat. 1999 Jan;53(2):121-35 [10326789.001]
  • [Cites] Oncogene. 1999 Apr 1;18(13):2201-11 [10327066.001]
  • [Cites] J Gen Virol. 1999 Jun;80 ( Pt 6):1513-7 [10374970.001]
  • [Cites] J Virol. 1999 Sep;73(9):7297-307 [10438818.001]
  • [Cites] J Natl Cancer Inst. 1999 Aug 18;91(16):1349-50 [10451431.001]
  • [Cites] J Gen Virol. 1999 Sep;80 ( Pt 9):2437-43 [10501499.001]
  • [Cites] J Exp Clin Cancer Res. 1999 Sep;18(3):369-77 [10606184.001]
  • [Cites] Semin Cancer Biol. 1999 Dec;9(6):413-22 [10712888.001]
  • [Cites] J Biol Chem. 2000 May 19;275(20):14824-30 [10809724.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):697-703 [10919740.001]
  • [Cites] Breast Cancer. 2000 Jan;7(1):33-6 [11029768.001]
  • [Cites] J Virol. 2000 Dec;74(24):11636-41 [11090162.001]
  • [Cites] J Virol. 2001 Jan;75(1):151-60 [11119584.001]
  • [Cites] Arch Virol. 2001;146(1):171-80 [11266212.001]
  • [Cites] Anticancer Res. 2001 Jan-Feb;21(1B):797-801 [11299846.001]
  • [Cites] Breast Cancer Res Treat. 1992;21(2):95-100 [1320958.001]
  • (PMID = 15642157.001).
  • [ISSN] 1465-542X
  • [Journal-full-title] Breast cancer research : BCR
  • [ISO-abbreviation] Breast Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Viral
  • [Other-IDs] NLM/ PMC1064094
  •  go-up   go-down


Advertisement
4. Beatty JD, Atwood M, Tickman R, Reiner M: Metaplastic breast cancer: clinical significance. Am J Surg; 2006 May;191(5):657-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Metaplastic breast carcinoma (MBC) is a rare poorly differentiated breast cancer characterized by coexistence of ductal carcinoma with areas of matrix producing, spindle-cell, sarcomatous, or squamous differentiation; ER/PR/HER2 negativity; and a reputation for poor outcome.
  • RESULTS: The mean metaplastic primary tumor diameter was 2.5 cm.
  • Increased, expression of EGFR (HER1) provides an opportunity for targeted tumor therapy.
  • [MeSH-major] Breast Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Humans. Middle Aged. Neoplasm Metastasis. Prospective Studies. Risk Factors. Survival Rate. Sweden / epidemiology


5. Waaga-Gasser AM, Gasser M, Stock M, Grimm M, Sprotte G: Oral immunoglobulin induces mononuclear cell apoptosis in patients suffering from idiopathic chronic pain syndrome: results from a pilot study. Int J Clin Pharmacol Ther; 2009 Jul;47(7):421-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral immunoglobulin induces mononuclear cell apoptosis in patients suffering from idiopathic chronic pain syndrome: results from a pilot study.
  • [MeSH-minor] Administration, Oral. Adult. Aged. Animals. Cattle. Child. Chronic Disease. Colostrum / immunology. Female. Hospitals, University. Humans. Insulin-Like Growth Factor I / analysis. Male. Middle Aged. Pilot Projects. Quality of Life

  • MedlinePlus Health Information. consumer health - Complex Regional Pain Syndrome.
  • MedlinePlus Health Information. consumer health - Fibromyalgia.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19640348.001).
  • [ISSN] 0946-1965
  • [Journal-full-title] International journal of clinical pharmacology and therapeutics
  • [ISO-abbreviation] Int J Clin Pharmacol Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Immunoglobulins; 67763-96-6 / Insulin-Like Growth Factor I
  •  go-up   go-down


6. Christensen E, Bofin A, Gudmundsdóttir I, Skogvoll E: Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grünwald-Giemsa stained cutaneous tissue smear. Cytopathology; 2008 Oct;19(5):316-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grünwald-Giemsa stained cutaneous tissue smear.
  • The aim of this study was to compare and evaluate the diagnostic performance of scrape cytology using two different cytological staining techniques, and to evaluate additional touch imprint cytology, with that of histopathology of basal cell carcinoma (BCC) and actinic keratosis (AK).
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Coloring Agents. Cytodiagnosis / methods. Eosine Yellowish-(YS) / metabolism. Keratosis / diagnosis. Methylene Blue / metabolism. Skin Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. METHYLENE BLUE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cytopathology. 2008 Oct;19(5):333-4; author reply 334 [18513288.001]
  • (PMID = 17916094.001).
  • [ISSN] 1365-2303
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / May-Grunwald Giemsa; T42P99266K / Methylene Blue; TDQ283MPCW / Eosine Yellowish-(YS)
  •  go-up   go-down


7. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ: Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Educ Res; 2007 Oct;22(5):691-702
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors.
  • Nearly 40% of mortality in the United States is linked to social and behavioral factors such as smoking, diet and sedentary lifestyle.
  • Autonomous self-regulation of health-related behaviors is thus an important aspect of human behavior to assess.
  • In 1997, the Behavior Change Consortium (BCC) was formed.
  • Within the BCC, seven health behaviors, 18 theoretical models, five intervention settings and 26 mediating variables were studied across diverse populations.
  • One of the measures included across settings and health behaviors was the Treatment Self-Regulation Questionnaire (TSRQ).
  • The purpose of the present study was to examine the validity of the TSRQ across settings and health behaviors (tobacco, diet and exercise).
  • The TSRQ is composed of subscales assessing different forms of motivation: amotivation, external, introjection, identification and integration.
  • Data were obtained from four different sites and a total of 2731 participants completed the TSRQ.
  • Invariance analyses support the validity of the TSRQ across all four sites and all three health behaviors.
  • Overall, the internal consistency of each subscale was acceptable (most alpha values >0.73).
  • The present study provides further evidence of the validity of the TSRQ and its usefulness as an assessment tool across various settings and for different health behaviors.
  • [MeSH-major] Health Behavior. Health Promotion / organization & administration. Surveys and Questionnaires
  • [MeSH-minor] Adolescent. Adult. Diet / psychology. Diet / statistics & numerical data. Exercise / psychology. Female. Humans. Male. Motivation. Reproducibility of Results. Self Efficacy. Smoking / epidemiology. Smoking / psychology. United States

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17138613.001).
  • [ISSN] 0268-1153
  • [Journal-full-title] Health education research
  • [ISO-abbreviation] Health Educ Res
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / R01-MH59594
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] England
  •  go-up   go-down


8. Rose H, Baldwin A, Dowson CG, Mahenthiralingam E: Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother; 2009 Mar;63(3):502-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biocide susceptibility of the Burkholderia cepacia complex.
  • OBJECTIVES: The Burkholderia cepacia complex (Bcc) species are important opportunistic pathogens with intrinsic antibiotic resistance.
  • They are also well known as contaminants of disinfectants, yet their biocide susceptibility has not been studied in detail.
  • We investigated Bcc biocide susceptibility and correlated it to their taxonomy, antibiotic susceptibility and ability to form biofilms.
  • METHODS: Genetically distinct Bcc strains belonging to 12 of the defined species were examined.
  • Biocide susceptibility was assessed by (i) broth dilution MIC assays, (ii) agar growth-based MBC screens and (iii) suspension tests.
  • Antibiotic MIC was determined by Etest strips, and the ability to form biofilms was examined in a 96-well plate assay.
  • RESULTS: Biocide susceptibility varied across the Bcc complex with high MIC recorded for chlorhexidine (>100 mg/L), cetylpyridinium chloride (>200 mg/L), triclosan (>500 mg/L), benzalkonium chloride (>400 mg/L) and povidone (>50 000 mg/L).
  • Species-dependent differences were apparent only for cetylpyridinium chloride.
  • There was no correlation between biocide susceptibility and (i) antibiotic susceptibility or (ii) the ability to form biofilms.
  • Biocide MBC was considerably higher than the MIC (chlorhexidine, 6-fold greater; cetylpyridinium chloride, 20-fold greater).
  • Cystic fibrosis outbreak strains (Burkholderia multivorans Glasgow strain and Burkholderia cenocepacia ET12) possessed elevated chlorhexidine resistance, and Bcc bacteria were also shown to remain viable in current commercial biocide formulations.
  • CONCLUSIONS: Bcc bacteria are resistant to a wide range of biocides and further representatives of this group should be included as reference strains in the development of new anti-infectives and commercial formulations.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Emerg Infect Dis. 2007 Mar;13(3):458-61 [17552100.001]
  • [Cites] Int J Syst Evol Microbiol. 2009 Jan;59(Pt 1):102-11 [19126732.001]
  • [Cites] Chest. 2007 Dec;132(6):1825-31 [17925414.001]
  • [Cites] J Clin Microbiol. 2000 Feb;38(2):910-3 [10655415.001]
  • [Cites] J Microbiol Methods. 2000 Apr;40(2):175-9 [10699673.001]
  • [Cites] J Infect Dis. 2002 May 15;185(10):1454-62 [11992281.001]
  • [Cites] Vox Sang. 2002 Jul;83(1):70-1 [12100392.001]
  • [Cites] J Antimicrob Chemother. 2002 Aug;50(2):265-9 [12161410.001]
  • [Cites] J Ind Microbiol Biotechnol. 2002 Nov;29(5):238-42 [12407457.001]
  • [Cites] J Heart Lung Transplant. 2002 Nov;21(11):1230-1 [12431498.001]
  • [Cites] Clin Microbiol Rev. 2003 Apr;16(2):189-208 [12692093.001]
  • [Cites] J Hosp Infect. 2003 May;54(1):63-7 [12767849.001]
  • [Cites] J Clin Microbiol. 2003 Jun;41(6):2797-8 [12791937.001]
  • [Cites] Curr Opin Pulm Med. 2003 Nov;9(6):509-15 [14534404.001]
  • [Cites] J Bacteriol. 2004 Jul;186(14):4427-40 [15231774.001]
  • [Cites] JAMA. 1976 Nov 22;236(21):2418-9 [989860.001]
  • [Cites] Am J Med. 1982 Aug;73(2):183-6 [7114074.001]
  • [Cites] Infect Control Hosp Epidemiol. 1991 May;12(5):297-302 [1865100.001]
  • [Cites] Thorax. 1995 Nov;50(11):1194-8 [8553277.001]
  • [Cites] J Clin Microbiol. 1997 Mar;35(3):614-9 [9041399.001]
  • [Cites] Thorax. 2004 Nov;59(11):952-4 [15516470.001]
  • [Cites] Nat Rev Microbiol. 2005 Feb;3(2):144-56 [15643431.001]
  • [Cites] J Clin Microbiol. 2005 Jun;43(6):2926-8 [15956421.001]
  • [Cites] J Clin Microbiol. 2005 Sep;43(9):4665-73 [16145124.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Feb 15;173(4):421-5 [16272450.001]
  • [Cites] PLoS One. 2006;1:e17 [17183643.001]
  • [Cites] PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):383-99 [18047177.001]
  • [Cites] J Clin Microbiol. 2008 Jan;46(1):290-5 [18032622.001]
  • [Cites] Infect Control Hosp Epidemiol. 2008 Apr;29(4):377-8 [18462153.001]
  • [Cites] J Appl Microbiol. 2008 Jun;104(6):1539-51 [18217926.001]
  • [Cites] Innate Immun. 2008 Jun;14(3):127-44 [18562572.001]
  • [Cites] Int J Syst Evol Microbiol. 2008 Jul;58(Pt 7):1580-90 [18599699.001]
  • [Cites] Future Microbiol. 2007 Apr;2(2):153-64 [17661652.001]
  • (PMID = 19153076.001).
  • [ISSN] 1460-2091
  • [Journal-full-title] The Journal of antimicrobial chemotherapy
  • [ISO-abbreviation] J. Antimicrob. Chemother.
  • [Language] ENG
  • [Grant] United Kingdom / Wellcome Trust / / 72853
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Disinfectants
  • [Other-IDs] NLM/ PMC2640157
  •  go-up   go-down


9. Syeed N, Husain SA, Abdullah S, Sameer AS, Chowdri NA, Nanda MS, Siddiqi MA: Mutational profile of the CAV-1 gene in breast cancer cases in the ethnic Kashmiri population. Asian Pac J Cancer Prev; 2010;11(4):1099-105
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore in our study we focused on the potential clinical relevance of Caveolin-1 in 130 malignant breast tissue specimens along with their adjacent normal tissues.
  • [MeSH-major] Breast Neoplasms / genetics. Breast Neoplasms, Male / genetics. Caveolin 1 / genetics

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Male Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21133631.001).
  • [ISSN] 2476-762X
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  • [Chemical-registry-number] 0 / Caveolin 1; 0 / Codon, Nonsense
  •  go-up   go-down


10. Seili-Bekafigo I, Jonjić N, Stemberger C, Rajković-Molek K: Additional cytomorphological criteria in diagnosis of pilomatricoma--benign tumor with bad reputation. Coll Antropol; 2010 Mar;34(1):117-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Additional cytomorphological criteria in diagnosis of pilomatricoma--benign tumor with bad reputation.
  • Pilomatricomas (PM) are benign skin appendageal tumors, with differentiation towards hair-forming cells, usually found in children.
  • PM are often mistaken for "small round blue cell" tumors in children, or for Merkel cell carcinoma, basalioma and metastatic small cell carcinoma in adults, with possible over-aggressive therapeutic approach.
  • Clinical, cytomorphologic and basic morphometric features were analyzed, and compared with 4 cases of malignant tumors with similar clinical presentation.
  • [MeSH-major] Carcinoma, Skin Appendage / pathology. Neoplasms / pathology. Pilomatrixoma / pathology. Sarcoma, Ewing / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy, Fine-Needle. Carcinoma, Basal Cell / pathology. Carcinoma, Merkel Cell / pathology. Child. Diagnosis, Differential. Eosine Yellowish-(YS). Epithelial Cells / pathology. Female. Humans. Male. Methylene Blue. Middle Aged

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • Hazardous Substances Data Bank. METHYLENE BLUE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20432739.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Croatia
  • [Chemical-registry-number] 0 / May-Grunwald Giemsa; T42P99266K / Methylene Blue; TDQ283MPCW / Eosine Yellowish-(YS)
  •  go-up   go-down


11. Dastgheib L, Monabati A, Mohammadian A, Sari-Aslani F, Marzban S, Namazi MR: Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin. J Cutan Pathol; 2009 Mar;36(3):314-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
  • Proteinase-activated receptor-2 (PAR-2) is a transmembrane G-protein expressed in many normal tissues and overexpressed in several cancer cell lines.
  • It contributes to metastasis, promotes epidermal growth factor receptor proliferation, angiogenesis and tumor progression in many carcinomas.
  • The purpose of this study was to investigate the expression of PAR-2 in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in comparison with that of normal skin.
  • Given the important role of PAR-2 in angiogenesis and metastasis, our finding can explain the far less aggressive behavior of BCC as compared with SCC.
  • [MeSH-major] Carcinoma, Basal Cell / metabolism. Carcinoma, Squamous Cell / metabolism. Gene Expression Regulation, Neoplastic. Head and Neck Neoplasms / metabolism. Receptor, PAR-2 / biosynthesis. Skin / metabolism. Skin Neoplasms / metabolism


12. Asuman C, Ozlem A, Burçak T, Onder P: An unusual location of basal cell carcinoma: the clitoris and the vulva. Indian J Dermatol; 2008;53(4):192-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual location of basal cell carcinoma: the clitoris and the vulva.
  • Vulvar basal cell carcinoma (BCC) is rare, accounting for less than 5% of all vulvar neoplasms and less than 1% of all BCCs.
  • The patient underwent wide local excision with clitoral amputation and remained disease free at post-surgical follow-up after 18 months.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 2005 Apr;97(1):192-4 [15790457.001]
  • [Cites] J Surg Oncol. 1999 Mar;70(3):172-6 [10102347.001]
  • [Cites] Gynecol Oncol. 2002 Jun;85(3):532-7 [12051887.001]
  • [Cites] Dermatol Surg. 1997 Mar;23(3):207-9 [9145965.001]
  • [Cites] Obstet Gynecol. 1997 Nov;90(5):765-8 [9351761.001]
  • (PMID = 19882033.001).
  • [ISSN] 1998-3611
  • [Journal-full-title] Indian journal of dermatology
  • [ISO-abbreviation] Indian J Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2763753
  • [Keywords] NOTNLM ; Basal cell carcinoma / clitoris / vulva
  •  go-up   go-down


13. Setny P, Zacharias M: Hydration in discrete water. A mean field, cellular automata based approach to calculating hydration free energies. J Phys Chem B; 2010 Jul 8;114(26):8667-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The construction of the effective Hamiltonian for a solvent cell provides an explicit coupling between orientation-dependent water-solute electrostatic interactions and water-water hydrogen bonding.

  • Hazardous Substances Data Bank. Water .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20552986.001).
  • [ISSN] 1520-5207
  • [Journal-full-title] The journal of physical chemistry. B
  • [ISO-abbreviation] J Phys Chem B
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Solvents; 059QF0KO0R / Water
  •  go-up   go-down


14. Lesiak A, Sysa-Jedrzejowska A, Narbutt J: [The role of sonic hedgehog pathway in skin carcinogenesis]. Pol Merkur Lekarski; 2010 Aug;29(170):141-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Non melanoma skin cancers (NMSC) involving basal (BCC)--and squamosus cell carcinomas (SCC) and are the most frequent skin cancers in Caucasians.
  • Under physiological conditions sonic hedgehog pathway is responsible for normal embryogenesis, regeneration of damaged tissues and for regulation of cell proliferation.
  • These events lead to deregulation of sonic hedgehog pathway trough activation of Smo protein and Gli transcriptional factors what stimulates cell proliferation and in consequence NMSC development.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Carcinoma, Squamous Cell / genetics. Hedgehog Proteins / genetics. Hedgehog Proteins / metabolism. Mutation. Skin Neoplasms / genetics
  • [MeSH-minor] Humans. Receptors, Cell Surface / metabolism. Receptors, G-Protein-Coupled / metabolism. Transcription Factors / metabolism

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20842831.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / GLI1 protein, human; 0 / Hedgehog Proteins; 0 / Receptors, Cell Surface; 0 / Receptors, G-Protein-Coupled; 0 / SMO protein, human; 0 / Transcription Factors; 0 / patched receptors
  •  go-up   go-down


15. Samolyuk GD, Miller GJ: Relation between chemical bonding and exchange coupling approaches to the description of ordering in itinerant magnets. J Comput Chem; 2008 Oct;29(13):2177-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relation between chemical bonding and exchange coupling approaches to the description of ordering in itinerant magnets.
  • Two different approaches to explain and predict the types of magnetic ordering in the 3d metal series and their compounds are reviewed.
  • According to the crossing theorem of Heine and Samson, the effective exchange coupling changes sign from negative (antiferromagnetic ordering) in the middle of 3d band to positive (ferromagnetic ordering) for the nearly empty or nearly filled d band cases.
  • On the other hand, the analytical properties of the Crystal Orbital Hamilton Population, which is a measure of chemical bonding, predict only one crossing at the center of the band in the region of nonbonding states.
  • Thus intermetallic compounds with Fermi energies falling within metal-metal nonbonding states are ordered antiferromagnetically whereas they order ferromagnetically when the Fermi levels fall within antibonding states.
  • The general character of these dependencies is demonstrated for various examples containing the magnetically active 3d metals, examples that include the bcc metals, Heusler alloys, and a series of novel quaternary intermetallic borides.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley Periodicals, Inc.
  • (PMID = 18566981.001).
  • [ISSN] 1096-987X
  • [Journal-full-title] Journal of computational chemistry
  • [ISO-abbreviation] J Comput Chem
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Love RR, Uy GB: Surgical oophorectomy for breast cancer: back to the future. Future Oncol; 2008 Dec;4(6):785-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In hormone-receptor-positive breast cancer, meta-analysis data from older trials, and more specific recent trial data have made clearer the chronic natural history of this broad subtype of disease and the central role of hormonal therapy in its control.
  • Greater understanding of the critical variables in pathology procedures for breast tumor tissue hormonal receptor testing is leading to better definitions of the specific patients for whom hormonal therapies are indicated.
  • [MeSH-major] Breast Neoplasms / surgery. Ovariectomy

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19086845.001).
  • [ISSN] 1744-8301
  • [Journal-full-title] Future oncology (London, England)
  • [ISO-abbreviation] Future Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Estrogen Antagonists; 0 / Receptors, Estrogen; 094ZI81Y45 / Tamoxifen
  • [Number-of-references] 44
  •  go-up   go-down


17. Chia KS: Gene-environment interactions in breast cancer. Novartis Found Symp; 2008;293:143-50; discussion 150-5, 181-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Some of this clustering occurs as part of specific familial breast cancer syndromes where disease results from single alleles conferring a high risk.
  • [MeSH-major] Breast Neoplasms / etiology. Environment. Genes / physiology
  • [MeSH-minor] Female. Genetic Predisposition to Disease. Humans. Risk Factors


18. Zhang HT, Lu YF, Zeng J, Lin J, Liao QH, Wan FQ: [Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers]. Zhonghua Wai Ke Za Zhi; 2007 Apr 1;45(7):480-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] BRCA1 Protein / genetics. BRCA2 Protein / genetics. Breast Neoplasms / genetics. Mutation

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17686308.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Apoptosis Regulatory Proteins; 0 / BLID protein, human; 0 / BRCA1 Protein; 0 / BRCA1 protein, human; 0 / BRCA2 Protein; 0 / BRCA2 protein, human
  •  go-up   go-down


19. Skeie G, Hjartåker A, Lund E: Diet among breast cancer survivors and healthy women. The Norwegian Women and Cancer Study. Eur J Clin Nutr; 2006 Sep;60(9):1046-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / psychology. Diet Surveys. Food Habits / psychology. Health Status. Life Style

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published online 15 February 2006.
  • (PMID = 16482067.001).
  • [ISSN] 0954-3007
  • [Journal-full-title] European journal of clinical nutrition
  • [ISO-abbreviation] Eur J Clin Nutr
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


20. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Yin R, Coull BA: Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978-2002 (United States). Cancer Causes Control; 2006 Mar;17(2):217-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16425100.001).
  • [ISSN] 0957-5243
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / PC / N01-PC-35139; United States / NCI NIH HHS / CA / R01 CA095983-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


21. Hadwin AM, Del Rio LF, Pinto LJ, Painter M, Routledge R, Moore MM: Microbial communities in wetlands of the Athabasca oil sands: genetic and metabolic characterization. FEMS Microbiol Ecol; 2006 Jan;55(1):68-78
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microbial communities in wetlands of the Athabasca oil sands: genetic and metabolic characterization.
  • Naphthenic acids are a complex family of naturally occurring cyclic and acyclic carboxylic acids that are present in the acidic fraction of petroleum.
  • Naphthenic acids are acutely toxic to aquatic organisms.
  • Previous studies showed that wetland sediments exposed to oil sands process water containing naphthenic acids had higher rates of naphthenic acid degradation in vitro compared with unexposed wetlands.
  • In this study we compare the microbial community structures in sediments from wetlands exposed to different amounts of oil sands process water using BIOLOG, phospholipid fatty acid analysis and denaturing gradient gel electrophoresis of total bacterial DNA.
  • Community profiles were compared using cluster analysis.
  • BIOLOG profiles were primarily influenced by seasonal trends rather than naphthenic acids content.
  • In contrast, phospholipid fatty acid analysis comparisons clustered communities that had higher levels of residual oil, although this association was not strong.
  • In contrast, cluster diagrams produced from the denaturing gradient gel electrophoresis data clearly separated bacterial communities according to naphthenic acids concentrations, indicating that naphthenic acids content was a major influence on the composition of the bacterial community.
  • In addition, denaturing gradient gel electrophoresis profiles indicated that naphthenic acids-exposed bacterial communities were homogeneous on a scale of meters, whereas unexposed (off-site) wetlands were less homogeneous.
  • [MeSH-major] Bacteria / isolation & purification. Colony Count, Microbial / methods. Industrial Microbiology
  • [MeSH-minor] Biodegradation, Environmental. Canada. Carboxylic Acids / chemistry. Carboxylic Acids / metabolism. DNA, Bacterial / genetics. Electrophoresis. Fatty Acids / analysis. Industrial Waste / analysis. Petroleum. Polymerase Chain Reaction. Reagent Kits, Diagnostic. Sensitivity and Specificity. Water Pollution, Chemical / analysis

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. NAPHTHENIC ACIDS .
  • Hazardous Substances Data Bank. NAPHTHENIC ACIDS, LEAD SALTS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16420616.001).
  • [ISSN] 0168-6496
  • [Journal-full-title] FEMS microbiology ecology
  • [ISO-abbreviation] FEMS Microbiol. Ecol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Carboxylic Acids; 0 / DNA, Bacterial; 0 / Fatty Acids; 0 / Industrial Waste; 0 / Petroleum; 0 / Reagent Kits, Diagnostic; 1338-24-5 / naphthenic acid
  •  go-up   go-down


22. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ: Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol; 2005 Nov;15(10):773-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.
  • PURPOSE: To compare male and female breast cancer and to determine the predictors of tumor characteristics and survival in both genders.
  • CONCLUSIONS: Some important gender differences were detected with respect to factors associated with tumor characteristics, but gender was not a significant predictor of survival after adjusting for the other demographic variables.
  • [MeSH-major] Breast Neoplasms / epidemiology. Breast Neoplasms / pathology. Breast Neoplasms, Male / epidemiology. Breast Neoplasms, Male / pathology. SEER Program / statistics & numerical data
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Functional Laterality. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Prognosis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Regression Analysis. Risk Factors. Sex Factors. Survival


23. Shinsuke K, Hirohiko K, Yasuhiro T, Kazuo H, Masayoshi I: Linear Basal cell carcinoma in an asian patient. Open Ophthalmol J; 2007;1:20-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Linear Basal cell carcinoma in an asian patient.
  • Linear basal cell carcinoma (BCC), which has a ratio of its long and short axes of more than 3: 1, is a distinct clinical entity among BCC.
  • The tumor was excised with 5 mm safety margin.
  • The pathological examination confirmed the tumor was a BCC with a clear margin.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plast Reconstr Surg. 1999 Jul;104(1):208-14 [10597698.001]
  • [Cites] J Plast Reconstr Aesthet Surg. 2006;59(4):419-23 [16756260.001]
  • [Cites] Ophthalmology. 2006 Feb;113(2):338-42 [16406534.001]
  • [Cites] Br J Plast Surg. 2005 Sep;58(6):795-805 [16086990.001]
  • [Cites] Lancet. 2004 Nov 13-19;364(9447):1766-72 [15541449.001]
  • [Cites] Dermatol Surg. 1999 Jan;25(1):63-7 [9935098.001]
  • [Cites] Br J Dermatol. 1999 Sep;141(3):415-23 [10583044.001]
  • [Cites] Cutis. 1993 Apr;51(4):287-9 [8477612.001]
  • [Cites] J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1118-26 [2273112.001]
  • [Cites] J Am Acad Dermatol. 1987 May;16(5 Pt 1):988-90 [3584583.001]
  • [Cites] Int J Dermatol. 1985 Mar;24(2):124-5 [3988420.001]
  • [Cites] Ophthalmology. 2004 Apr;111(4):631-6 [15051193.001]
  • [Cites] Ophthalmology. 2004 Apr;111(4):624-30 [15051192.001]
  • [Cites] Int J Dermatol. 1995 Jul;34(7):488 [7591413.001]
  • (PMID = 19478861.001).
  • [ISSN] 1874-3641
  • [Journal-full-title] The open ophthalmology journal
  • [ISO-abbreviation] Open Ophthalmol J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC2605696
  •  go-up   go-down


24. Vanhaecke L, Grootaert C, Verstraete W, Van de Wiele T: Chemopreventive effects from prebiotic inulin towards microbial 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine bioactivation. J Appl Microbiol; 2009 Feb;106(2):474-85
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chemopreventive effects from prebiotic inulin towards microbial 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine bioactivation.
  • AIMS: Using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME), we investigated the chemopreventive potential of prebiotic chicory inulin towards the in vitro bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human intestinal microbiota.
  • METHODS AND RESULTS: HPLC data revealed that inulin significantly decreased the formation of the genotoxic PhIP-M1 metabolite, with the highest inhibitory activity in the colon ascendens (87% decrease).
  • Interestingly, this chemopreventive effect correlated with alterations of bacterial community composition and metabolism in the different colon compartments.
  • Conventional culture-based techniques and PCR-DGGE analysis on the SHIME colon suspension revealed significant bifidogenic effects during inulin treatment, whereas the overall microbial community kept relatively unchanged.
  • Additionally, the production of short-chain fatty acids increased with 12%, 3% and 7%, while ammonia concentrations decreased with 3%, 4% and 3% in the ascending, transverse and descending colon compartments, respectively.
  • CONCLUSIONS: These results indicate that the prebiotic effects from inulin may also purport protective effects towards microbial PhIP bioactivation.
  • SIGNIFICANCE AND IMPACT OF THE STUDY: As the colonic microbiota may contribute significantly to the carcinogenic potential of PhIP, the search for dietary constituents that decrease the formation of this harmful metabolite, may help in preventing its risk towards human health.
  • [MeSH-major] Imidazoles / metabolism. Inulin / pharmacology. Mutagens / metabolism. Prebiotics
  • [MeSH-minor] Bacteria / genetics. Bacteria / growth & development. Bacteria / metabolism. Chicory / chemistry. Colon / metabolism. Colon / microbiology. Colony Count, Microbial. DNA Fingerprinting. Fatty Acids, Volatile / metabolism. Fermentation. Humans. Pyrimidines / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19200315.001).
  • [ISSN] 1365-2672
  • [Journal-full-title] Journal of applied microbiology
  • [ISO-abbreviation] J. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido(3',2'-4,5)imidazo(1,2-a)pyrimidin-5-ium; 0 / Fatty Acids, Volatile; 0 / Imidazoles; 0 / Mutagens; 0 / Prebiotics; 0 / Pyrimidines; 9005-80-5 / Inulin; 909C6UN66T / 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
  •  go-up   go-down


25. Folman LB, Klein Gunnewiek PJ, Boddy L, de Boer W: Impact of white-rot fungi on numbers and community composition of bacteria colonizing beech wood from forest soil. FEMS Microbiol Ecol; 2008 Feb;63(2):181-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of white-rot fungi on numbers and community composition of bacteria colonizing beech wood from forest soil.
  • White-rot fungi are important wood-decomposing organisms in forest ecosystems.
  • Their ability to colonize and decompose woody resources may be strongly influenced by wood-inhabiting bacteria that grow on easily utilizable compounds e.g. oligomers of wood-polymers released by fungal enzymes.
  • However, so far, it is not known how white-rot fungi deal with the presence of potential competing bacteria.
  • Here, the effects of two white-rot fungi, Hypholoma fasciculare and Resinicium bicolor, on the numbers and composition of bacteria colonizing sterile beech wood blocks from forest soil are reported.
  • Both total numbers (microscopic counts) and the numbers of cultivable wood-inhabiting bacteria were considerably lower in wood blocks that became colonized by the white-rot fungi than in control blocks.
  • This points to the fungi out-competing the opportunistic bacteria.
  • The presence of white-rot fungi resulted in a change in the relative abundance of families of cultivable bacteria in wood and also in a change of denaturing gradient gel electrophoresis patterns of directly amplified 16S rRNA gene fragments.
  • Analysis of the bacterial community structure in soil adhering to exploratory mycelium (cords) indicated that fungal species-specific effects on bacterial community composition were also apparent in this fungal growth phase.
  • [MeSH-major] Bacteria / isolation & purification. Basidiomycota. Soil Microbiology. Wood / microbiology
  • [MeSH-minor] Base Sequence. Colony Count, Microbial. Fagus / microbiology. Molecular Sequence Data. Phylogeny. RNA, Bacterial / genetics. RNA, Ribosomal, 16S / genetics. Sequence Analysis, RNA

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18199083.001).
  • [ISSN] 0168-6496
  • [Journal-full-title] FEMS microbiology ecology
  • [ISO-abbreviation] FEMS Microbiol. Ecol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EF027740/ EF027741/ EF027742/ EF027743/ EF027744/ EF027745/ EF027746/ EF027747/ EF027748/ EF027749/ EF027750/ EF027751/ EF027752/ EF027753/ EF027754/ EF027755/ EF027756/ EF027757/ EF027758/ EF027759/ EF027760/ EF027761/ EF027762/ EF027763/ EF027764/ EF027765/ EF027766/ EF027767/ EF027768/ EF027769/ EF027770/ EF027771/ EF027772/ EF027773/ EF027774/ EF027775/ EF027776/ EF027777/ EF027778/ EF027779/ EF027780/ EF027781/ EF027782/ EF027783/ EF027784/ EF027785/ EF027786/ EF027787/ EF027788/ EF027789/ EF027790/ EF027791/ EF027792/ EF027793/ EF027794/ EF027795/ EF027796/ EF027797/ EF027798/ EF027799/ EF027800/ EF027801/ EF027802/ EF027803/ EF027804/ EF027805/ EF027806/ EF027807/ EF027808/ EF027809/ EF027810/ EF027811/ EF027812/ EF027813/ EF027814/ EF027815/ EF027816/ EF027817/ EF027818/ EF027819/ EF027820/ EF027821/ EF027822/ EF027823/ EF027824/ EF027825/ EF027826/ EF027827/ EF027828/ EF027829/ EF027830/ EF027831/ EF027832/ EF027833/ EF027834/ EF027835/ EF027836/ EF027837/ EF027838/ EF027839/ EF027840/ EF027841/ EF027842/ EF027843/ EF027844/ EF027845/ EF027846/ EF027847/ EF027848/ EF027849/ EF027850/ EF027851/ EF027852/ EF027853/ EF027854/ EF027855/ EF027856/ EF027857/ EF027858
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


26. Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G: Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol; 2007 11;22(11):1221-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
  • Gross cystic disease fluid protein (GCDFP-15) and mammaglobin are both widely used and accepted markers for epithelia of breast origin.
  • Both markers strongly correlated with each other and were significantly associated with lower tumour grading.
  • Additionally, GCDFP-15 negativity was significantly associated with shortened disease-free survival times in univariate and multivariate analyses.
  • The significantly longer disease free survival times for patients with GCDFP-15 positive tumours clearly warrants further study.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Breast Neoplasms / metabolism. Carcinoma, Ductal, Breast / metabolism. Carcinoma, Lobular / metabolism. Carrier Proteins / metabolism. Glycoproteins / metabolism. Neoplasm Proteins / metabolism. Uteroglobin / metabolism
  • [MeSH-minor] Cell Count. Disease-Free Survival. Female. Humans. Mammaglobin A. Middle Aged. Survival Rate

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17647195.001).
  • [ISSN] 1699-5848
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carrier Proteins; 0 / Glycoproteins; 0 / Mammaglobin A; 0 / Neoplasm Proteins; 0 / PIP protein, human; 0 / SCGB2A2 protein, human; 9060-09-7 / Uteroglobin
  •  go-up   go-down


27. Gautier T, Tietge UJ, Boverhof R, Perton FG, Le Guern N, Masson D, Rensen PC, Havekes LM, Lagrost L, Kuipers F: Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. J Lipid Res; 2007 Jan;48(1):30-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein.
  • The impact of apolipoprotein C-I (apoC-I) deficiency on hepatic lipid metabolism was addressed in mice in the presence or the absence of cholesteryl ester transfer protein (CETP).
  • In addition to the expected moderate reduction in plasma cholesterol levels, apoCIKO mice showed significant increases in the hepatic content of cholesteryl esters (+58%) and triglycerides (+118%) and in biliary cholesterol concentration (+35%) as compared with wild-type mice.
  • In the presence of CETP, hepatic alterations resulting from apoC-I deficiency were enforced, with up to 58% and 302% increases in hepatic levels of cholesteryl esters and triglycerides in CETPTg/apoCIKO mice versus CETPTg mice, respectively.
  • Biliary levels of cholesterol, phospholipids, and bile acids were increased by 88, 77, and 20%, respectively, whereas total cholesterol, HDL cholesterol, and triglyceride concentrations in plasma were further reduced in CETPTg/apoCIKO mice versus CETPTg mice.
  • Finally, apoC-I deficiency was not associated with altered VLDL production rate.
  • In line with the previously recognized inhibition of lipoprotein clearance by apoC-I, apoC-I deficiency led to decreased plasma lipid concentration, hepatic lipid accumulation, and increased biliary excretion of cholesterol.
  • The effect was even greater when the alternate reverse cholesterol transport pathway via VLDL/LDL was boosted in the presence of CETP.
  • [MeSH-major] Apolipoprotein C-I / deficiency. Cholesterol Ester Transfer Proteins / metabolism. Lipids / physiology. Liver / metabolism
  • [MeSH-minor] Animals. Gallbladder / metabolism. Mice. Mice, Inbred C57BL. Mice, Knockout. Polymerase Chain Reaction. RNA / genetics. RNA / isolation & purification


28. Butler DF, Parekh PK, Lenis A: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study. Dermatol Surg; 2009 Jan;35(1):24-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
  • BACKGROUND: Imiquimod 5% cream is currently approved for treatment of nonfacial, superficial basal cell carcinomas (BCCs).
  • Only five of 12 patients (42%) in the treatment group were found histologically clear of tumor (complete responders).
  • [MeSH-major] Aminoquinolines / administration & dosage. Antineoplastic Agents / administration & dosage. Carcinoma, Basal Cell / therapy. Mohs Surgery. Nose Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dermatol Surg. 2010 Mar;36(3):428-30 [20402949.001]
  • (PMID = 19018814.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aminoquinolines; 0 / Antineoplastic Agents; 0 / Ointments; 99011-02-6 / imiquimod
  •  go-up   go-down


29. Nemet AY, Deckel Y, Martin PA, Kourt G, Chilov M, Sharma V, Benger R: Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol; 2006 Aug;142(2):293-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
  • PURPOSE: To analyze the outcome of management of patients with basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) in a tertiary referral eye center in Sydney, Australia.
  • MAIN OUTCOME MEASURES: Survival period free of tumor, incomplete excision, recurrences, type of closure, and complications.
  • Twenty-seven patients (5.6%) had a recurrent tumor.
  • MMS is the safer technique after incomplete tumor excision.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / surgery. Eyelid Neoplasms / surgery. Neoplasm Recurrence, Local. Skin Neoplasms / surgery


30. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS: Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol; 2008 Sep;159(4):931-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • First skin cancers recorded in study patients were 27 basal cell carcinomas (BCC), seven squamous cell carcinomas (SCC) and six melanomas.
  • [MeSH-major] Neoplasms, Radiation-Induced / etiology. Skin Neoplasms / etiology. Ultraviolet Therapy / adverse effects


31. Bose S, Puthucode A, Banerjee R, Ayyub P: The influence of nanoscale phase separation and devitrification on the electrical transport properties of amorphous Cu-Nb alloy thin films. J Phys Condens Matter; 2009 Jul 15;21(28):285305
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The influence of nanoscale phase separation and devitrification on the electrical transport properties of amorphous Cu-Nb alloy thin films.
  • The formation of amorphous phases in immiscible alloys with a large positive enthalpy of mixing is thermodynamically unfavorable.
  • Co-sputter deposited Cu-Nb films exhibit a nanoscale phase separation into Cu-rich and Nb-rich amorphous regions.
  • They show relatively high room temperature resistivity, a negative temperature coefficient of resistance (TCR), and an incomplete superconducting transition with onset at 3.7 K.
  • Annealing the nanophase-separated amorphous films at 200 °C results in the nucleation of fcc Cu-rich nanocrystals within an Nb-rich amorphous matrix.
  • This film exhibits multiple resistance steps, eventually showing a sharp drop with (T(C))(onset) = 3.7 K.
  • Annealing at 350 °C leads to complete devitrification via the formation of large bcc Nb-rich grains encapsulating the existing fcc Cu nanocrystals.
  • These films show low room temperature resistivity, positive TCR, and a sharp superconducting transition with onset at 5.2 K.
  • The electrical transport and superconducting behavior appear to be consistent with a two-stage crystallization process.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21828518.001).
  • [ISSN] 0953-8984
  • [Journal-full-title] Journal of physics. Condensed matter : an Institute of Physics journal
  • [ISO-abbreviation] J Phys Condens Matter
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


32. Teran J, Sifakis E, Blemker SS, Ng-Thow-Hing V, Lau C, Fedkiw R: Creating and simulating skeletal muscle from the visible human data set. IEEE Trans Vis Comput Graph; 2005 May-Jun;11(3):317-28
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Creating and simulating skeletal muscle from the visible human data set.
  • Simulation of the musculoskeletal system has important applications in biomechanics, biomedical engineering, surgery simulation, and computer graphics.
  • The accuracy of the muscle, bone, and tendon geometry as well as the accuracy of muscle and tendon dynamic deformation are of paramount importance in all these applications.
  • We present a framework for extracting and simulating high resolution musculoskeletal geometry from the segmented visible human data set.
  • We simulate 30 contact/collision coupled muscles in the upper limb and describe a computationally tractable implementation using an embedded mesh framework.
  • Muscle geometry is embedded in a nonmanifold, connectivity preserving simulation mesh molded out of a lower resolution BCC lattice containing identical, well-shaped elements, leading to a relaxed time step restriction for stability and, thus, reduced computational cost.
  • The muscles are endowed with a transversely isotropic, quasi-incompressible constitutive model that incorporates muscle fiber fields as well as passive and active components.
  • The simulation takes advantage of a new robust finite element technique that handles both degenerate and inverted tetrahedra.
  • [MeSH-major] Algorithms. Computer Graphics. Imaging, Three-Dimensional / methods. Models, Biological. Muscle, Skeletal / anatomy & histology. Muscle, Skeletal / physiology. Visible Human Projects
  • [MeSH-minor] Artificial Intelligence. Computer Simulation. Elasticity. Finite Element Analysis. Humans. Image Enhancement / methods. Image Interpretation, Computer-Assisted / methods. Information Storage and Retrieval / methods. Muscle Contraction / physiology. Stress, Mechanical. User-Computer Interface

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15868831.001).
  • [ISSN] 1077-2626
  • [Journal-full-title] IEEE transactions on visualization and computer graphics
  • [ISO-abbreviation] IEEE Trans Vis Comput Graph
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD38962
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Validation Studies
  • [Publication-country] United States
  •  go-up   go-down


33. Kidd TJ, Douglas JM, Bergh HA, Coulter C, Bell SC: Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Res Microbiol; 2008 Apr;159(3):194-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
  • The Burkholderia cepacia complex (Bcc) is a group of significant opportunistic respiratory pathogens which affect people with cystic fibrosis.
  • In this study, we sought to ascertain the epidemiology and geographic species distribution of 116 Bcc isolates collected from people with CF in Australia and New Zealand.
  • We performed a combination of recA-based PCR, amplified rDNA restriction analysis (ARDRA), pulsed-field gel electrophoresis and repetitive extragenic palindromic PCR on each isolate.
  • Each Burkholderia cenocepacia isolate was also screened by PCR for the presence of the B. cepacia epidemic strain marker.
  • One hundred and fourteen isolates were assigned to a species using recA-based PCR and ARDRA. B. cenocepacia, B. multivorans and B. cepacia accounted for 45.7%, 29.3% and 11.2% of the isolates, respectively.
  • Strain analysis of B. cenocepacia revealed that 85.3% of the isolates were unrelated.
  • One related B. cenocepacia strain was identified amongst 15 people.
  • Whilst full details of person-to-person contact was not available, all patients attended CF centres in Queensland (Qld) and New South Wales (NSW).
  • Although person-to-person transmission of B. cenocepacia strains has occurred in Australia, the majority of CF-related Bcc infections in Australia and New Zealand are most likely acquired from the environment.
  • [MeSH-major] Burkholderia Infections / epidemiology. Burkholderia Infections / microbiology. Burkholderia cepacia complex / isolation & purification. Cystic Fibrosis / microbiology. Polymerase Chain Reaction / methods
  • [MeSH-minor] Australia / epidemiology. Bacterial Proteins / genetics. Bacterial Typing Techniques. DNA, Bacterial / genetics. DNA, Ribosomal / genetics. Electrophoresis, Gel, Pulsed-Field. Humans. New Zealand / epidemiology. Polymorphism, Restriction Fragment Length. Rec A Recombinases / genetics

  • Genetic Alliance. consumer health - BabysFirstTest - Cystic Fibrosis.
  • Genetic Alliance. consumer health - Cystic Fibrosis.
  • MedlinePlus Health Information. consumer health - Cystic Fibrosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18356026.001).
  • [ISSN] 0923-2508
  • [Journal-full-title] Research in microbiology
  • [ISO-abbreviation] Res. Microbiol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / DNA, Bacterial; 0 / DNA, Ribosomal; EC 2.7.7.- / Rec A Recombinases
  •  go-up   go-down


34. Erb P, Ji J, Wernli M, Kump E, Glaser A, Büchner SA: Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol Lett; 2005 Aug 15;100(1):68-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of apoptosis in basal cell and squamous cell carcinoma formation.
  • Long-term ultraviolet-light (UV) exposure of human skin epidermis is associated with an increased risk for the development of skin cancers, such as melanoma, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
  • If the DNA damage is not repaired or the damaged cells are not eliminated by apoptosis, the consequence can be cell transformation, uncontrolled proliferation and eventually skin tumor formation.
  • Excessive UV exposure can mutate the p53 gene leading to the loss of its repair function and thus apoptosis resistance of the DNA-damaged cell.
  • In addition, BCC and SCC strongly express the apoptosis-inducing Fas-ligand (FasL) which may help the tumor to escape the attack of immune effector cells.
  • Silencing the genes involved in tumor formation by RNA interference might become a promising new approach to treat skin tumors.
  • [MeSH-major] Apoptosis. Carcinoma, Basal Cell / metabolism. Carcinoma, Squamous Cell / metabolism. Gene Expression Regulation, Neoplastic / radiation effects. Signal Transduction / radiation effects. Skin Neoplasms / metabolism. Ultraviolet Rays / adverse effects
  • [MeSH-minor] Animals. DNA Damage / genetics. DNA Damage / radiation effects. Fas Ligand Protein. Hedgehog Proteins. Humans. Membrane Glycoproteins / biosynthesis. Membrane Glycoproteins / genetics. Mice. Mutation. Trans-Activators / genetics. Trans-Activators / metabolism. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16054233.001).
  • [ISSN] 0165-2478
  • [Journal-full-title] Immunology letters
  • [ISO-abbreviation] Immunol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / FASLG protein, human; 0 / Fas Ligand Protein; 0 / Fasl protein, mouse; 0 / Hedgehog Proteins; 0 / Membrane Glycoproteins; 0 / Trans-Activators; 0 / Tumor Suppressor Protein p53
  • [Number-of-references] 24
  •  go-up   go-down


35. Hanavadi S, Monypenny IJ, Mansel RE: Is mammography overused in male patients? Breast; 2006 Feb;15(1):123-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms, Male / radiography. Mammography / utilization

  • MedlinePlus Health Information. consumer health - Male Breast Cancer.
  • MedlinePlus Health Information. consumer health - Mammography.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16473746.001).
  • [ISSN] 0960-9776
  • [Journal-full-title] Breast (Edinburgh, Scotland)
  • [ISO-abbreviation] Breast
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


36. Reisinger DM, Shiffer JD, Cognetta AB Jr, Chang Y, Moore PS: Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J Am Acad Dermatol; 2010 Sep;63(3):400-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
  • BACKGROUND: Merkel cell polyomavirus (MCV) was discovered by digital transcriptome subtraction as a monoclonal infection of Merkel cell carcinoma (MCC) tumors.
  • OBJECTIVE: We sought to directly assay for MCV infection in squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) tumor cells by immunostaining for viral antigen.
  • [MeSH-major] Carcinoma, Basal Cell / virology. Carcinoma, Merkel Cell / virology. Carcinoma, Squamous Cell / virology. Immunocompetence. Skin Neoplasms / virology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20584559.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA120726; United States / NCI NIH HHS / CA / CA136363
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Polyomavirus Transforming; 0 / DNA, Viral
  •  go-up   go-down


37. Langenheder S, Lindström ES, Tranvik LJ: Structure and function of bacterial communities emerging from different sources under identical conditions. Appl Environ Microbiol; 2006 Jan;72(1):212-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to compare two major hypotheses concerning the formation of bacterial community composition (BCC) at the local scale, i.e., whether BCC is determined by the prevailing local environmental conditions or by "metacommunity processes."

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • Hazardous Substances Data Bank. BENZOIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2004 Dec 9;432(7018):747-50 [15592411.001]
  • [Cites] Appl Environ Microbiol. 1999 Aug;65(8):3721-6 [10427073.001]
  • [Cites] Appl Environ Microbiol. 2005 Jan;71(1):227-39 [15640192.001]
  • [Cites] Environ Microbiol. 2005 Mar;7(3):301-13 [15683391.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8201-6 [16332803.001]
  • [Cites] FEMS Microbiol Ecol. 2004 Jul 1;49(1):71-82 [19712385.001]
  • [Cites] Appl Environ Microbiol. 2000 Apr;66(4):1692-7 [10742262.001]
  • [Cites] Appl Environ Microbiol. 2000 Jul;66(7):3044-51 [10877804.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):5053-65 [11055963.001]
  • [Cites] Appl Environ Microbiol. 2000 Dec;66(12):5448-56 [11097926.001]
  • [Cites] Environ Microbiol. 2000 Apr;2(2):191-201 [11220305.001]
  • [Cites] Microb Ecol. 2003 Feb;45(2):173-82 [12545315.001]
  • [Cites] Appl Environ Microbiol. 2003 Mar;69(3):1442-51 [12620827.001]
  • [Cites] Appl Environ Microbiol. 2003 May;69(5):2555-62 [12732521.001]
  • [Cites] Appl Environ Microbiol. 2003 Jul;69(7):3701-9 [12839735.001]
  • [Cites] Oecologia. 2003 Aug;136(4):489-98 [12836009.001]
  • [Cites] Appl Environ Microbiol. 2003 Sep;69(9):5248-54 [12957910.001]
  • [Cites] Appl Environ Microbiol. 2003 Oct;69(10):5875-83 [14532039.001]
  • [Cites] Oecologia. 2004 Mar;139(1):98-107 [14740289.001]
  • [Cites] Proc Biol Sci. 2004 Jan 22;271(1535):113-22 [15058386.001]
  • [Cites] Appl Environ Microbiol. 2004 Jun;70(6):3425-33 [15184140.001]
  • [Cites] Curr Opin Microbiol. 2004 Jun;7(3):221-6 [15196488.001]
  • [Cites] Appl Environ Microbiol. 2004 Aug;70(8):4831-9 [15294821.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):750-3 [15592412.001]
  • (PMID = 16391045.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carbon Radioisotopes; 0 / DNA, Bacterial; 0 / RNA, Ribosomal, 16S; 8SKN0B0MIM / Benzoic Acid
  • [Other-IDs] NLM/ PMC1352196
  •  go-up   go-down


38. Nouri K, Ballard CJ, Bouzari N, Saghari S: Basal cell carcinoma of the areola in a man. J Drugs Dermatol; 2005 May-Jun;4(3):352-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma of the areola in a man.
  • Basal cell carcinomas (BCCs) that arise in sun-protected sites are quite uncommon.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Nipples / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15898292.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Boukamp P: Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis; 2005 Oct;26(10):1657-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-melanoma skin cancer: what drives tumor development and progression?
  • Non-melanoma skin cancer, i.e. basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequent tumors and their number is still increasing worldwide.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Carcinoma, Squamous Cell / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Disease Progression. Genes, myc. Genes, ras. Humans. Loss of Heterozygosity. Papillomaviridae / isolation & purification

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15905207.001).
  • [ISSN] 0143-3334
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Number-of-references] 152
  •  go-up   go-down


40. Mostafa WZ, Mahfouz SM, Bosseila M, Sobhi RM, El-Nabarawy E: An immunohistochemical study of laminin in basal cell carcinoma. J Cutan Pathol; 2010 Jan;37(1):68-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An immunohistochemical study of laminin in basal cell carcinoma.
  • BACKGROUND: Laminins are components of the extracellular matrix that mediate cell adhesion, growth, migration, proliferation and differentiation.
  • Basement membrane (BM) laminins, in particular, may play a role in enhancing carcinoma cell motility.
  • AIM: To evaluate the distribution pattern of laminin in basal cell carcinoma (BCC), as regards the basement membrane, cellular cytoplasm, peritumoral lacunae and surface epithelium and to correlate laminin distribution with different variants of BCC.
  • Most laminin was in basement membrane zone (BMZ), and the more differentiated the tumor, the more cytoplasmic and BM staining it expressed.
  • [MeSH-major] Carcinoma, Basal Cell / metabolism. Laminin / metabolism. Skin Neoplasms / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Biopsy. Child. Female. Humans. Immunohistochemistry / methods. Male. Middle Aged. Skin Aging. Young Adult

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 John Wiley & Sons A/S.
  • (PMID = 19615022.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Laminin
  •  go-up   go-down


41. Taneja S, Evans AJ, Rakha EA, Green AR, Ball G, Ellis IO: The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. Clin Radiol; 2008 Nov;63(11):1228-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-five proteins of known relevance in breast cancer were assessed, including hormone receptors, HER-2 status, basal and luminal markers, p53 expression, and E-cadherin.
  • Groups characterized by HER-2 overexpression, basal characteristics, and E-cadherin positivity had a significantly higher proportion of ill-defined masses.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Breast Neoplasms / metabolism. Breast Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Cadherins / metabolism. Female. Humans. Lymphatic Metastasis. Mammography. Middle Aged. Neoplasm Invasiveness. Neoplasm Proteins / metabolism. Receptor, ErbB-2 / metabolism. Retrospective Studies. Tumor Suppressor Protein p53 / metabolism


42. Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML: Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol; 2008 Feb 15;167(4):447-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states.
  • Diabetes mellitus has been associated with breast cancer, although no studies appear to have adequately assessed the association in Hispanic women, a population with a high prevalence of diabetes.
  • The authors investigated this association in a population-based case-control study of Hispanic and non-Hispanic White women living in the southwestern United States.
  • Breast cancer cases diagnosed in 1999-2004 were identified through state cancer registries (1,526 non-Hispanic Whites, 798 Hispanics).
  • Age- and ethnicity-matched controls (1,599 non-Hispanic Whites, 924 Hispanics) were selected from commercial mailing lists and driver's license and Social Security records.
  • Diabetes history was assessed through interviewer-administered questionnaires.
  • Odds ratios and 95% confidence intervals were calculated using logistic regression, adjusting for age, body mass index at age 15 years, and parity.
  • Having any type of diabetes was not associated with breast cancer overall (odds ratio = 0.94, 95% confidence interval: 0.78, 1.12).
  • Type 2 diabetes was observed among 19% of Hispanics and 9% of non-Hispanic Whites but was not associated with breast cancer in either group.
  • Gestational diabetes was inversely associated with breast cancer in both ethnic groups, especially when first diagnosed at age < or =35 years (odds ratio = 0.54, 95% confidence interval: 0.37, 0.79).
  • In this study, diabetes was not associated with breast cancer overall, although the inverse association with gestational diabetes warrants further investigation.

  • Genetic Alliance. consumer health - Diabetes.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Hispanic American Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Care. 2003 Apr;26(4):1047-51 [12663571.001]
  • [Cites] Breast Cancer Res Treat. 2008 Mar;108(1):129-35 [17476589.001]
  • [Cites] Int J Epidemiol. 1999 Oct;28(5):816-23 [10597976.001]
  • [Cites] J Natl Cancer Inst. 1970 Mar;44(3):673-86 [11515436.001]
  • [Cites] JAMA. 2002 Jan 16;287(3):356-9 [11790215.001]
  • [Cites] Cancer Causes Control. 2001 Dec;12(10):875-80 [11808705.001]
  • [Cites] Am J Epidemiol. 2002 Aug 15;156(4):349-52 [12181105.001]
  • [Cites] Cancer. 2004 Jan 1;100(1):149-55 [14692035.001]
  • [Cites] Cancer Causes Control. 2004 Apr;15(3):267-75 [15090721.001]
  • [Cites] Diabetes Care. 2004 May;27(5):1194-9 [15111544.001]
  • [Cites] Am J Epidemiol. 2004 Jun 15;159(12):1160-7 [15191933.001]
  • [Cites] Int J Cancer. 1974 Aug 15;14(2):153-60 [4378317.001]
  • [Cites] J Chronic Dis. 1982;35(1):13-9 [7068798.001]
  • [Cites] J Chronic Dis. 1985;38(5):435-41 [3998058.001]
  • [Cites] Diabetes Metab Rev. 1990 Feb;6(1):29-45 [2192854.001]
  • [Cites] Eur J Cancer. 1990;26(7):781-5 [2145895.001]
  • [Cites] Int J Gynaecol Obstet. 1991 May;35(1):13-8 [1680070.001]
  • [Cites] Diabetes Care. 1991 Jul;14(7):695-705 [1914821.001]
  • [Cites] Am J Epidemiol. 1992 May 1;135(9):965-73 [1595695.001]
  • [Cites] Epidemiology. 1994 Jan;5(1):102-8 [8117767.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):807-11 [8634649.001]
  • [Cites] Prev Med. 1997 Jan-Feb;26(1):144-53 [9010910.001]
  • [Cites] Int J Cancer. 1997 May 2;71(3):360-3 [9139868.001]
  • [Cites] Br J Cancer. 1997;75(11):1699-703 [9184190.001]
  • [Cites] J Natl Cancer Inst. 1997 Sep 17;89(18):1360-5 [9308706.001]
  • [Cites] Lancet. 1998 May 9;351(9113):1393-6 [9593409.001]
  • [Cites] Diabetes. 1998 Aug;47(8):1302-10 [9703332.001]
  • [Cites] Am J Epidemiol. 1998 Oct 1;148(7):683-92 [9778175.001]
  • [Cites] Epidemiology. 1998 Nov;9(6):641-7 [9799175.001]
  • [Cites] J Intern Med. 1997 Jun;241(6):471-5 [10497622.001]
  • [Cites] JAMA. 2005 Jan 12;293(2):194-202 [15644546.001]
  • [Cites] J Natl Cancer Inst. 2005 Mar 16;97(6):439-48 [15770008.001]
  • [Cites] Br J Cancer. 2005 Jun 6;92(11):2070-5 [15886700.001]
  • [Cites] Diabetes Care. 2006 Jun;29(6):1263-8 [16732006.001]
  • [Cites] Asian Pac J Cancer Prev. 2006 Apr-Jun;7(2):253-9 [16839219.001]
  • [Cites] Breast Cancer Res Treat. 2006 Aug;98(3):349-56 [16541321.001]
  • [Cites] Arch Intern Med. 2006 Sep 25;166(17):1871-7 [17000944.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):142-50 [17220343.001]
  • [Cites] Cancer Causes Control. 2007 Jun;18(5):505-15 [17437179.001]
  • [Cites] Int J Cancer. 2007 Aug 15;121(4):856-62 [17397032.001]
  • [Cites] Breast Cancer Res Treat. 2007 Mar;102(1):85-101 [17080310.001]
  • [Cites] Carcinogenesis. 2007 Jul;28(7):1561-6 [17440036.001]
  • [Cites] Breast Cancer Res Treat. 2007 Aug;104(2):197-209 [17051426.001]
  • [Cites] Diabetes Care. 2003 Jun;26(6):1752-8 [12766105.001]
  • (PMID = 18033764.001).
  • [ISSN] 1476-6256
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA078682-07; United States / NCI NIH HHS / CA / CA078682; United States / NCI NIH HHS / CA / R01 CA078552; United States / NCI NIH HHS / CA / R01 CA078762; United States / NCI NIH HHS / CA / CA078682-07; United States / NCI NIH HHS / CA / R01 CA078802; United States / NCI NIH HHS / CA / R01 CA078682; United States / NCI NIH HHS / CA / CA078552; United States / NCI NIH HHS / PC / N01-PC-67000; United States / NCI NIH HHS / CA / CA078762; United States / NCI NIH HHS / CA / CA078802
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS50878; NLM/ PMC2925515
  •  go-up   go-down


43. Centers for Disease Control and Prevention (CDC): Decline in breast cancer incidence--United States, 1999-2003. MMWR Morb Mortal Wkly Rep; 2007 Jun 8;56(22):549-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17557070.001).
  • [ISSN] 1545-861X
  • [Journal-full-title] MMWR. Morbidity and mortality weekly report
  • [ISO-abbreviation] MMWR Morb. Mortal. Wkly. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR, Pankratz VS, Cerhan JR, Vachon CM: Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control; 2007 Jun;18(5):505-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / complications. Breast Neoplasms / epidemiology. Diabetes Mellitus, Type 2 / epidemiology. Mammography


45. Ishihara K, Saida T, Otsuka F, Yamazaki N, Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society: Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol; 2008 Feb;13(1):33-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
  • BACKGROUND: In the previous report of the Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society, we tabulated data on patients with malignant melanoma who had been registered at major medical institutions (22 institutions on average) in Japan over 5-year periods from 1987 to 1991 (group A) and from 1992 to 1996 (group B).
  • Because the International Union Against Cancer (UICC) TNM and stage classifications for malignant melanoma were changed substantially in 2002, analyses in the present investigation were performed according to the new classifications.
  • In addition, the numbers of patients with various kinds of skin malignancies, including not only malignant melanoma but also basal cell carcinoma, squamous cell carcinoma, mycosis fungoides, actinic keratosis, Bowen's disease, and Paget's disease, registered at approximately 100 medical institutions in Japan from 1987 to 2001, were also investigated and data were tabulated.
  • RESULTS: The nationwide survey of Japanese patients with malignant skin tumors from 1987 to 2001 showed that the most prevalent skin tumor was basal cell carcinoma, which increased year by year, followed by squamous cell carcinoma, and then by malignant melanoma.
  • For patients in stage III, the overall survival rate was higher in group C than that in group A or B, while there was no apparent difference in survival between the groups for patients in stage I or II.
  • For patients in stage IV, the survival rate in group C was slightly lower than that in group A or B. (7) In group C, the overall survival rates for substages III A, B, and C were ranked as III A > III B > III C. (8) The overall survival rates for stage IV M1a, M1b, and M1c were ranked as M1a > M1b > M1c.
  • CONCLUSION: In Japan, the number of patients with malignant skin tumors has increased year by year.
  • The prognosis of patients with advanced malignant melanoma remains extremely poor, but that of patients in stage III has shown an improvement.
  • [MeSH-major] Melanoma / epidemiology. Skin Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Epidemiol. 1995 Oct;24(5):897-907 [8557445.001]
  • [Cites] Int J Clin Oncol. 2003 Jun;8(3):139-50 [12851837.001]
  • [Cites] Int J Clin Oncol. 2001 Jun;6(3):109-16 [11706778.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1484-91 [10717634.001]
  • [Cites] J Clin Oncol. 2001 Aug 15;19(16):3635-48 [11504745.001]
  • [Cites] Harefuah. 1995 Jun 15;128(12):745-51, 824 [7557679.001]
  • (PMID = 18307017.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


46. Keller B, Braathen LR, Marti HP, Hunger RE: Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly; 2010;140:w13036
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND/AIMS: Skin tumours, in particular squamous-cell carcinomas (SCC), are the most common malignant conditions developing in transplant recipients.
  • RESULTS: We found an increased risk of actinic keratosis (AK) and SCC in renal transplant recipients with a basal cell carcinoma (BCC) / SCC ratio of 1:7.
  • [MeSH-major] Carcinoma, Basal Cell / immunology. Carcinoma, Squamous Cell / immunology. Keratosis, Actinic / immunology. Kidney Transplantation / immunology. Postoperative Complications / immunology. Precancerous Conditions / immunology. Skin Neoplasms / immunology


47. Aulmann C, Seufert P, Sandherr M, Schlimok G, Schulze R, Oruzio D: [A 65-year-old female patient with breast cancer accompanied by thrombocytopenia and hyperfibrinolysis]. Internist (Berl); 2007 Sep;48(9):1015-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor diseases can be accompanied by paraneoplastic syndromes.
  • A tumour disease with disturbed hemostasis caused by both plasmatic coagulation and thrombocytopenia has not yet been reported.
  • [MeSH-major] Breast Neoplasms / complications. Breast Neoplasms / diagnosis. Fibrinolysis. Hemorrhagic Disorders / complications. Hemorrhagic Disorders / diagnosis. Thrombocytopenia / complications. Thrombocytopenia / diagnosis

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Oncol. 1999 Aug;22(4):411-3 [10440202.001]
  • [Cites] South Med J. 2002 Nov;95(11):1335-7 [12540004.001]
  • [Cites] Thromb Haemost. 2001 Sep;86(3):828-33 [11583315.001]
  • [Cites] Am J Clin Pathol. 1979 Jan;71(1):10-6 [420161.001]
  • [Cites] Am J Clin Oncol. 2000 Feb;23(1):74-7 [10683084.001]
  • [Cites] Respir Med. 2004 Feb;98(2):93-8 [14971870.001]
  • [Cites] Semin Thromb Hemost. 1996;22(6):459-78 [9122711.001]
  • [Cites] J Cancer Res Clin Oncol. 1997;123(10):555-9 [9393589.001]
  • [Cites] Jpn J Clin Oncol. 2001 Aug;31(8):388-94 [11574632.001]
  • [Cites] N Engl J Med. 1994 Nov 3;331(18):1207-11 [7935660.001]
  • [Cites] Blood Coagul Fibrinolysis. 2004 Jan;15(1):9-13 [15166937.001]
  • (PMID = 17704902.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


48. Bendesky A, Rosales A, Salazar AM, Sordo M, Peniche J, Ostrosky-Wegman P: p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res; 2007 Jun 1;619(1-2):38-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is not known, however, whether this polymorphism influences genome stability.
  • We analyzed whether p53 codon 72 genotype influences genomic stability and the sensitivity of cells to UVB.
  • There was no association between p53 genotype and basal levels of DNA damage, oxidative DNA damage sensitivity, or DNA repair capacity.
  • There was no significant association either between p53 genotype and basal cell carcinoma (BCC), squamous cell carcinoma (SCC) or both combined.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Carcinoma, Squamous Cell / genetics. DNA Damage / genetics. DNA Repair / genetics. Genes, p53. Polymorphism, Genetic. Skin Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17403527.001).
  • [ISSN] 0027-5107
  • [Journal-full-title] Mutation research
  • [ISO-abbreviation] Mutat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Codon; 0 / DNA Primers
  •  go-up   go-down


49. Tsai KC, Chen YC, Hsiao NW, Wang CL, Lin CL, Lee YC, Li M, Wang B: A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies. Eur J Med Chem; 2010 Apr;45(4):1544-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies.
  • Computational chemistry is playing an increasingly important role in drug design and discovery, structural biology, and quantitative structure-activity relationship (QSAR) studies.
  • For QSAR work, selecting an appropriate and accurate method to assign the electrostatic potentials of each atom in a molecule is a critical first step.
  • So far several commonly used methods are available to assign charges.
  • However, no systematic comparison of the effects of electrostatic potentials on QSAR quality has been made.
  • In this study, twelve semi-empirical and empirical charge-assigning methods, AM1, AM1-BCC, CFF, Del-Re, Formal, Gasteiger, Gasteiger-Hückel, Hückel, MMFF, PRODRG, Pullman, and VC2003 charges, have been compared for their performances in CoMFA and CoMSIA modeling using several standard datasets.
  • Some charge assignment models, such as Del-Re, PRODRG, and Pullman, are limited to specific atom and bond types, and, therefore, were excluded from this study.
  • Among the remaining nine methods, the Gasteiger-Hückel charge, though commonly used, performed poorly in prediction accuracy.
  • The AM1-BCC method was better than most charge-assigning methods based on prediction accuracy, though it was not successful in yielding overall higher cross-validation correlation coefficient (q(2)) values than others.
  • The CFF charge model worked the best in prediction accuracy when q(2) was used as the evaluation criterion.
  • The results presented should help the selection of electrostatic potential models in CoMFA and CoMSIA studies.
  • [MeSH-major] Static Electricity
  • [MeSH-minor] Models, Molecular. Quantitative Structure-Activity Relationship

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20110138.001).
  • [ISSN] 1768-3254
  • [Journal-full-title] European journal of medicinal chemistry
  • [ISO-abbreviation] Eur J Med Chem
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  •  go-up   go-down


50. Stanton BZ, Peng LF: Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst; 2010 Jan;6(1):44-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Shh binds to its receptor, Patched (Ptch1), resulting in the de-repression of Smoothened (Smo).
  • Small-molecule modulators of Shh signaling provide a means to regulate the activity of a pathway implicated in medulloblastoma, basal cell carcinoma (BCC), pancreatic cancer, prostate cancer and developmental disorders.

  • Hazardous Substances Data Bank. CYCLOPAMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20024066.001).
  • [ISSN] 1742-2051
  • [Journal-full-title] Molecular bioSystems
  • [ISO-abbreviation] Mol Biosyst
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anilides; 0 / CUR 61414; 0 / Dioxoles; 0 / GANT58; 0 / Hedgehog Proteins; 0 / HhAntag691; 0 / IPI-926; 0 / Piperazines; 0 / Pyrazoles; 0 / Pyridines; 0 / Receptors, G-Protein-Coupled; 0 / SANT-1 compound; 0 / SMO protein, human; 0 / Thiophenes; 0 / Veratrum Alkaloids; ZH658AJ192 / cyclopamine
  • [Number-of-references] 89
  •  go-up   go-down


51. Peitsch WK, Hofmann I, Bulkescher J, Hergt M, Spring H, Bleyl U, Goerdt S, Franke WW: Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes. J Invest Dermatol; 2005 Oct;125(4):761-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes.
  • Isoform E2 of drebrin, an actin-binding protein originally identified in neuronal cells, has recently been identified in diverse non-neuronal cells, mostly in association with cell processes and intercellular junctions.
  • By immunohistochemistry and immunoblot, basal cell carcinomas (BCC) are rich in drebrin, and confocal laser scanning and immunoelectron microscopy show accumulation at adhering junctions, in co-localization with actin and partially with plaque proteins.
  • In squamous cell carcinomas, keratoacanthomas, and in epidermal precancers, drebrin is heterogeneously distributed, appearing as mosaics.
  • When epithelium-derived cells devoid of drebrin are transfected with drebrin-enhanced green fluorescent protein, constructs accumulate in the cell periphery, and immunoprecipitation shows complexes with actin.
  • During epidermal growth factor induced formation of cell processes, drebrin retains this junction association, as observed by live cell microscopy.
  • Our results suggest novel functions of drebrin such as an involvement in cell-cell adhesion and tumorigenesis and a potential value in diagnosis of BCC.
  • [MeSH-major] Keratinocytes / metabolism. Microfilament Proteins / analysis. Neoplasms, Glandular and Epithelial / chemistry. Neuropeptides / analysis. Skin Neoplasms / chemistry
  • [MeSH-minor] Cell Line, Tumor. Epidermal Growth Factor / pharmacology. Female. Fluorescent Antibody Technique. Humans. Immunoblotting. Microscopy, Confocal. Microscopy, Immunoelectron. Skin / chemistry. Transfection

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16185277.001).
  • [ISSN] 0022-202X
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Microfilament Proteins; 0 / Neuropeptides; 0 / drebrin E; 62229-50-9 / Epidermal Growth Factor
  •  go-up   go-down


52. Turkovic L, Gurrin LC, Bahlo M, Dite GS, Southey MC, Hopper JL: Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. BMC Cancer; 2010;10:466
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] BRCA1 Protein / genetics. BRCA2 Protein / genetics. Breast Neoplasms / genetics. Genetic Predisposition to Disease. Germ-Line Mutation / genetics. Haplotypes / genetics. Polymorphism, Genetic / genetics
  • [MeSH-minor] Adolescent. Adult. Australia. Case-Control Studies. Female. Founder Effect. Humans. Middle Aged. Neoplasm Staging. Prognosis. Risk Factors. Survival Rate. Young Adult

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genome Res. 2001 Jan;11(1):143-51 [11156623.001]
  • [Cites] Breast Cancer Res Treat. 2009 Jul;116(2):379-86 [18704680.001]
  • [Cites] Am J Hum Genet. 2002 Feb;70(2):425-34 [11791212.001]
  • [Cites] Hum Mutat. 2002 Jul;20(1):65-73 [12112659.001]
  • [Cites] J Natl Cancer Inst. 2003 Mar 19;95(6):448-57 [12644538.001]
  • [Cites] Eur J Hum Genet. 2003 Jun;11(6):489-92 [12774043.001]
  • [Cites] Am J Hum Genet. 2003 Nov;73(5):1162-9 [14574645.001]
  • [Cites] Am J Hum Genet. 2004 Jan;74(1):106-20 [14681826.001]
  • [Cites] Am J Hum Genet. 2004 Jul;75(1):35-43 [15148658.001]
  • [Cites] Hum Mol Genet. 2004 Oct 15;13(20):2431-41 [15317758.001]
  • [Cites] Hum Mol Genet. 1997 Feb;6(2):285-9 [9063749.001]
  • [Cites] J Natl Cancer Inst. 1998 Apr 1;90(7):532-6 [9539249.001]
  • [Cites] Bioinformatics. 2005 Jan 15;21(2):263-5 [15297300.001]
  • [Cites] Breast Cancer Res. 2005;7(2):R171-5 [15743496.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7516-22 [16103107.001]
  • [Cites] Am J Hum Genet. 2001 Apr;68(4):978-89 [11254454.001]
  • (PMID = 20807450.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / BRCA1 Protein; 0 / BRCA1 protein, human; 0 / BRCA2 Protein; 0 / BRCA2 protein, human
  • [Other-IDs] NLM/ PMC2940805
  •  go-up   go-down


53. Silva Idos S, De Stavola B, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer: Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med; 2008 Sep 30;5(9):e193
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies.
  • BACKGROUND: Birth size, perhaps a proxy for prenatal environment, might be a correlate of subsequent breast cancer risk, but findings from epidemiological studies have been inconsistent.
  • We re-analysed individual participant data from published and unpublished studies to obtain more precise estimates of the magnitude and shape of the birth size-breast cancer association.
  • METHODS AND FINDINGS: Studies were identified through computer-assisted and manual searches, and personal communication with investigators.
  • Individual participant data from 32 studies, comprising 22,058 breast cancer cases, were obtained.
  • Random effect models were used, if appropriate, to combine study-specific estimates of effect.
  • Birth weight was positively associated with breast cancer risk in studies based on birth records (pooled relative risk [RR] per one standard deviation [SD] [= 0.5 kg] increment in birth weight: 1.06; 95% confidence interval [CI] 1.02-1.09) and parental recall when the participants were children (1.02; 95% CI 0.99-1.05), but not in those based on adult self-reports, or maternal recall during the woman's adulthood (0.98; 95% CI 0.95-1.01) (p for heterogeneity between data sources = 0.003).
  • Relative to women who weighed 3.000-3.499 kg, the risk was 0.96 (CI 0.80-1.16) in those who weighed < 2.500 kg, and 1.12 (95% CI 1.00-1.25) in those who weighed > or = 4.000 kg (p for linear trend = 0.001) in birth record data.
  • Birth length and head circumference from birth records were also positively associated with breast cancer risk (pooled RR per one SD increment: 1.06 [95% CI 1.03-1.10] and 1.09 [95% CI 1.03-1.15], respectively).
  • Simultaneous adjustment for these three birth size variables showed that length was the strongest independent predictor of risk.
  • The birth size effects did not appear to be confounded or mediated by established breast cancer risk factors and were not modified by age or menopausal status.
  • The cumulative incidence of breast cancer per 100 women by age 80 y in the study populations was estimated to be 10.0, 10.0, 10.4, and 11.5 in those who were, respectively, in the bottom, second, third, and top fourths of the birth length distribution.
  • CONCLUSIONS: This pooled analysis of individual participant data is consistent with birth size, and in particular birth length, being an independent correlate of breast cancer risk in adulthood.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Birth Weight.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1664-6 [14583767.001]
  • [Cites] Int J Cancer. 2003 Dec 20;107(6):997-1000 [14601061.001]
  • [Cites] Br J Cancer. 2004 Nov 1;91(9):1666-8 [15477861.001]
  • [Cites] Br J Cancer. 1988 Apr;57(4):437-9 [3390382.001]
  • [Cites] Lancet. 1990 Apr 21;335(8695):939-40 [1970028.001]
  • [Cites] Lancet. 1992 Oct 24;340(8826):1015-8 [1357410.001]
  • [Cites] Biometrics. 1992 Sep;48(3):795-806 [1420842.001]
  • [Cites] Epidemiology. 1996 Jan;7(1):34-7 [8664398.001]
  • [Cites] Lancet. 1996 Dec 7;348(9041):1542-6 [8950880.001]
  • [Cites] J Natl Cancer Inst. 1997 Jan 1;89(1):71-6 [8978409.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1997 May;24(5):497-505 [9161941.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Oct;82(10):3281-4 [9329354.001]
  • [Cites] Paediatr Perinat Epidemiol. 1998 Oct;12(4):397-407 [9805713.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Mar;84(3):1145-8 [10084609.001]
  • [Cites] Am J Epidemiol. 1999 Apr 15;149(8):726-9 [10206622.001]
  • [Cites] Cancer Causes Control. 1999 Feb;10(1):85-94 [10334647.001]
  • [Cites] Pediatr Nurs. 1999 Jan-Feb;25(1):13-7 [10335245.001]
  • [Cites] Breast Cancer Res. 2004;6(6):R656-67 [15535848.001]
  • [Cites] Int J Cancer. 2005 Apr 10;114(3):461-4 [15551343.001]
  • [Cites] Int J Cancer. 2005 Jul 1;115(4):611-7 [15700315.001]
  • [Cites] Diabetologia. 2005 Sep;48(9):1736-42 [16052327.001]
  • [Cites] Cancer Causes Control. 2006 May;17(4):395-401 [16596291.001]
  • [Cites] Am J Epidemiol. 2006 Jun 1;163(11):1053-64 [16624970.001]
  • [Cites] Br J Cancer. 2006 Jun 5;94(11):1734-7 [16641898.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1469-72 [16896034.001]
  • [Cites] Obesity (Silver Spring). 2006 Jul;14(7):1257-63 [16899807.001]
  • [Cites] Int J Cancer. 2006 Nov 1;119(9):2136-41 [16804898.001]
  • [Cites] Int J Cancer. 2006 Nov 1;119(9):2007-25 [16823839.001]
  • [Cites] Trends Endocrinol Metab. 2006 Nov;17(9):340-8 [16997567.001]
  • [Cites] Carcinogenesis. 2006 Dec;27(12):2464-8 [16777984.001]
  • [Cites] Breast Cancer Res. 2007;9(3):R29 [17501995.001]
  • [Cites] Int J Cancer. 2008 Feb 1;122(3):481-5 [18022897.001]
  • [Cites] Lancet Oncol. 2007 Dec;8(12):1088-100 [18054879.001]
  • [Cites] Epidemiology. 2008 Mar;19(2):197-203 [18300695.001]
  • [Cites] Breast Cancer Res. 2008;10(1):R8 [18205956.001]
  • [Cites] Pediatr Res. 1999 Nov;46(5):491-5 [10541308.001]
  • [Cites] Epidemiology. 2000 May;11(3):315-9 [10784250.001]
  • [Cites] J Natl Cancer Inst. 2000 May 17;92(10):840-1 [10814680.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):964-8 [10970703.001]
  • [Cites] Am J Epidemiol. 2000 Sep 15;152(6):514-27 [10997541.001]
  • [Cites] J Natl Cancer Inst. 2001 Jan 3;93(1):60-2 [11136844.001]
  • [Cites] Int J Cancer. 2001 Jan 15;91(2):248-51 [11146453.001]
  • [Cites] Am J Epidemiol. 2000 Dec 15;152(12):1121-8 [11130617.001]
  • [Cites] Br J Cancer. 2001 May 4;84(9):1193-8 [11336470.001]
  • [Cites] Stat Med. 2001 Jul 30;20(14):2115-30 [11439425.001]
  • [Cites] Acta Obstet Gynecol Scand. 2001 Oct;80(10):931-6 [11580738.001]
  • [Cites] Br J Cancer. 2001 Nov 30;85(11):1680-4 [11742488.001]
  • [Cites] Br J Cancer. 2002 Jan 7;86(1):84-8 [11857016.001]
  • [Cites] Br J Cancer. 2002 Jan 7;86(1):89-91 [11857017.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):207-10 [11867509.001]
  • [Cites] Pediatrics. 2002 Jun;109(6):1131-5 [12042554.001]
  • [Cites] Semin Perinatol. 2002 Aug;26(4):260-7 [12211616.001]
  • [Cites] Br J Cancer. 2002 Nov 18;87(11):1234-45 [12439712.001]
  • [Cites] Am J Epidemiol. 2003 Feb 1;157(3):258-66 [12543626.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Dec;88(12):5656-60 [14671149.001]
  • [Cites] Br J Cancer. 2004 Aug 2;91(3):519-24 [15266328.001]
  • [Cites] Obstet Gynecol. 2004 Oct;104(4):671-7 [15458884.001]
  • [Cites] Obstet Gynecol. 2004 Oct;104(4):720-6 [15458892.001]
  • [Cites] N Engl J Med. 2004 Oct 14;351(16):1619-26 [15483280.001]
  • [Cites] BMJ. 2003 Feb 1;326(7383):248 [12560272.001]
  • [Cites] Breast Cancer Res. 2003;5(1):42-4 [12559045.001]
  • [Cites] Cancer Causes Control. 2003 Feb;14(1):61-4 [12708726.001]
  • [Cites] Cancer Causes Control. 2003 May;14(4):347-55 [12846366.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):860-5 [14504195.001]
  • [CommentIn] PLoS Med. 2008 Sep 30;5(9):e194 [18828668.001]
  • (PMID = 18828667.001).
  • [ISSN] 1549-1676
  • [Journal-full-title] PLoS medicine
  • [ISO-abbreviation] PLoS Med.
  • [Language] ENG
  • [Grant] United Kingdom / Cancer Research UK / / C14292/A5609; United Kingdom / Cancer Research UK / / C150/A5660
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2553821
  •  go-up   go-down


54. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst; 2006 Oct 4;98(19):1406-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / epidemiology. Breast Neoplasms / metabolism. Gonadal Steroid Hormones / blood. Premenopause

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Natl Cancer Inst. 2007 Mar 7;99(5):408-9; author reply 409-10 [17341734.001]
  • (PMID = 17018787.001).
  • [ISSN] 1460-2105
  • [Journal-full-title] Journal of the National Cancer Institute
  • [ISO-abbreviation] J. Natl. Cancer Inst.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA50385; United States / NCI NIH HHS / CA / CA67262; United States / NCI NIH HHS / CA / R25 CA098566-02; United States / NCI NIH HHS / CA / T32 CA090001-281
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Androgens; 0 / Estrogens; 0 / Gonadal Steroid Hormones; 0 / Sex Hormone-Binding Globulin; 4TI98Z838E / Estradiol
  •  go-up   go-down


55. Dong X, Reddy GB: Soil bacterial communities in constructed wetlands treated with swine wastewater using PCR-DGGE technique. Bioresour Technol; 2010 Feb;101(4):1175-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soil bacterial communities in constructed wetlands treated with swine wastewater using PCR-DGGE technique.
  • Marsh-pond-marsh (MPM) constructed wetlands were designed for the treatment of swine wastewater.
  • The goal of this study was to characterize bacterial communities in these wetlands and determine the nutrient removal from influent to effluent.
  • Surface soil samples were collected and analyzed by culture-dependent and culture-independent techniques.
  • The results showed that the bacterial colony forming units (CFU) and the average concentrations of total nitrogen, NH(4)(+), total phosphorous (TP) and PO(4)(3-) from the influent to the effluent decreased.
  • The NH(4)(+) and the PO(4)(3-) concentrations showed the most dramatic changes, with decreases of 39.97% and 16.92%, respectively.
  • Data of culture-independent samples produced by using PCR-denaturing gradient gel electrophoresis (DGGE) technique showed that the Shannon diversity index and richness decreased significantly (P<0.05) from influent to effluent.
  • Bacterium species distributions strongly correlated with the concentrations of TP, NH(4)(+) and the PO(4)(3-).
  • Sequencing of partial 16S rRNA genes fragments revealed that the total bacterial community composition was dominated by Pseudomonas sp., Arthrobacter sp., Bacillus sp. and other soil bacteria.
  • Anammox (anaerobic ammonium oxidation) stains were detected.
  • Phylogenetic analysis demonstrated that some of the partial 16S rRNA gene sequences had close relationships with unculturable denitrification bacteria.
  • The activities of these bacteria might contribute to the nutrient removal in the wetlands.
  • [MeSH-major] Bacteria / growth & development. Electrophoresis, Agar Gel / methods. Polymerase Chain Reaction / methods. Soil Microbiology. Sus scrofa. Waste Disposal, Fluid. Wetlands
  • [MeSH-minor] Animals. Biodiversity. Cluster Analysis. Colony Count, Microbial. Environment. Nucleic Acid Denaturation. Phylogeny. Principal Component Analysis. RNA, Ribosomal, 16S / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19822421.001).
  • [ISSN] 1873-2976
  • [Journal-full-title] Bioresource technology
  • [ISO-abbreviation] Bioresour. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


56. Scheithauer BK, Wos-Oxley ML, Ferslev B, Jablonowski H, Pieper DH: Characterization of the complex bacterial communities colonizing biliary stents reveals a host-dependent diversity. ISME J; 2009 Jul;3(7):797-807
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of the complex bacterial communities colonizing biliary stents reveals a host-dependent diversity.
  • This study provides a comprehensive survey of the spatial and temporal bacterial composition of biliary stent biofilms.
  • The bacterial diversity, distribution and dynamics of 59 biliary and 4 pancreatic stent communities from 40 patients being treated at two different hospitals, which implant stents either simultaneously or consecutively, were characterized by single-strand conformation polymorphism (SSCP) analysis.
  • Fifty-one phylotypes belonging to 5 bacterial phyla and 24 bacterial families were detected across 63 stents.
  • This is a much broader diversity than previously detected through culture-dependent methods, particularly in regard to the diversity of obligate anaerobes.
  • Stent bacterial diversity was patient-dependent and more similar when stents were implanted simultaneously rather than consecutively.
  • Stent bacterial community composition differed between hospitals specifically because of the difference in abundance of Bifidobacteria.
  • Co-colonization of Veillonella sp., Streptococcus anginosus and organisms closely related to Fusobacterium nucleatum revealed a potentially important attachment and survival strategy that has yet to be reported in biliary stents.
  • This work reveals a more complete survey of the identities of bacterial species that form biofilms in biliary stents, their co-colonization patterns and the natural variation in species composition between different patients, hospitals and locations along the stent.
  • Consideration of the community composition from individual patients will allow tailoring of prophylactic antibiotic treatments and thus will make the management of stent biofilms more effective.
  • [MeSH-major] Bacteria / classification. Bacteria / isolation & purification. Biodiversity. Common Bile Duct / microbiology. Stents / microbiology
  • [MeSH-minor] Cluster Analysis. DNA, Ribosomal / genetics. Humans. Molecular Sequence Data. Phylogeny. Polymorphism, Single-Stranded Conformational. RNA, Ribosomal, 16S / genetics. Sequence Analysis, DNA

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19360025.001).
  • [ISSN] 1751-7370
  • [Journal-full-title] The ISME journal
  • [ISO-abbreviation] ISME J
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EU704129/ EU704130/ EU704131/ EU704132/ EU704133/ EU704134/ EU704135/ EU704136/ EU704137/ EU704138/ EU704139/ EU704140/ EU704141/ EU704142/ EU704143/ EU704144/ EU704145/ EU704146/ EU704147/ EU704148/ EU704149/ EU704150/ EU704151/ EU704152/ EU704153/ EU704154/ EU704155/ EU704156/ EU704157/ EU704158/ EU704159/ EU704160/ EU704161/ EU704162/ EU704163/ EU704164/ EU704165/ EU704166/ EU704167/ EU704168/ EU704169/ EU704170/ EU704171/ EU704172/ EU704173/ EU704174/ EU704175/ EU704176/ EU704177/ EU704178/ EU704179/ EU704180/ EU704181/ EU704182/ EU704183/ EU704184/ EU704185/ EU704186/ EU704187/ EU704188/ EU704189/ EU704190/ EU704191/ EU704192/ EU704193/ EU704194/ EU704195/ EU704196/ EU704197/ EU704198/ EU704199/ EU704200/ EU704201/ EU704202/ EU704203/ EU704204/ EU704205/ EU704206/ EU704207/ EU704208/ EU704209/ EU704210/ EU704211/ EU704212/ EU704213/ EU704214/ EU704215/ EU704216/ EU704217/ EU704218/ EU704219/ EU704220/ EU704221/ EU704222/ EU704223/ EU704224/ EU704225/ EU704226/ EU704227/ EU704228/ EU704229/ EU704230/ EU704231/ EU704232/ EU704233/ EU704234/ EU704235/ EU704236/ EU704237/ EU704238/ EU704239/ EU704240/ EU704241/ EU704242/ EU704243/ EU704244/ EU704245/ EU704246/ EU704247/ EU704248/ EU704249/ EU704250/ EU915501/ EU915502/ EU915503/ EU915504
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


57. Wang Z, Xu Y, Tang J, Ma H, Qin J, Lu C, Wang X, Hu Z, Wang X, Shen H: A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women. Breast Cancer Res Treat; 2009 Nov;118(1):169-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Exodeoxyribonucleases / genetics. Genes, Neoplasm. Menarche / genetics. Neoplasm Proteins / genetics. Polymorphism, Single Nucleotide. RecQ Helicases / genetics. Werner Syndrome / genetics
  • [MeSH-minor] Adult. Aged. Amino Acid Substitution. Case-Control Studies. China / epidemiology. Female. Genes, BRCA1. Genetic Predisposition to Disease. Genotype. Humans. Menopause. Middle Aged. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Risk

  • Genetic Alliance. consumer health - Werner's syndrome.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205873.001).
  • [ISSN] 1573-7217
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; EC 3.1.- / Exodeoxyribonucleases; EC 3.6.1.- / Bloom syndrome protein; EC 3.6.1.- / WRN protein, human; EC 3.6.4.12 / RecQ Helicases
  •  go-up   go-down


58. Kuo WH, Yen AM, Lee PH, Chen KM, Wang J, Chang KJ, Chen TH, Tsau HS: Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. Br J Cancer; 2009 Feb 24;100(4):563-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development.
  • [MeSH-major] Breast Neoplasms / mortality. Breast Neoplasms / pathology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2000 May 27;355(9218):1869-74 [10866443.001]
  • [Cites] Eur J Cancer. 2008 Dec;44(18):2774-80 [19027287.001]
  • [Cites] World J Surg. 2001 Sep;25(9):1117-24 [11571945.001]
  • [Cites] Int J Cancer. 2004 Mar 1;108(6):901-6 [14712495.001]
  • [Cites] Arch Surg. 2004 Jan;139(1):27-30; discussion 31 [14718270.001]
  • [Cites] Cancer. 1984 Dec 15;54(12):3002-11 [6498774.001]
  • [Cites] Aust N Z J Surg. 1989 Jan;59(1):35-7 [2913992.001]
  • [Cites] J Natl Cancer Inst. 1993 Nov 17;85(22):1819-27 [8230262.001]
  • [Cites] Cancer. 1993 Dec 15;72(12):3629-35 [8252478.001]
  • [Cites] Am J Epidemiol. 1995 Dec 15;142(12):1255-64 [7503045.001]
  • [Cites] N Engl J Med. 1996 Jan 18;334(3):143-9 [8531968.001]
  • [Cites] Int J Epidemiol. 1996 Feb;25(1):40-5 [8666502.001]
  • [Cites] Am J Clin Oncol. 1997 Dec;20(6):541-5 [9391536.001]
  • [Cites] Int J Oncol. 1999 Jun;14(6):1103-9 [10339665.001]
  • [Cites] Fam Cancer. 2004;3(3-4):249-57 [15516849.001]
  • [Cites] Int J Cancer. 2005 Jan 10;113(2):302-6 [15386413.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):243-50 [15668501.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1687-717 [15894097.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1986-90 [16103449.001]
  • [Cites] Lancet. 2005 Dec 17;366(9503):2087-106 [16360786.001]
  • [Cites] Breast Cancer Res Treat. 2006 Sep;99(2):221-8 [16544057.001]
  • [Cites] BMC Cancer. 2006;6:261 [17078893.001]
  • [Cites] J Clin Oncol. 2007 Jun 10;25(17):2360-8 [17515570.001]
  • [Cites] Int J Cancer. 2007 Sep 1;121(5):1017-20 [17471561.001]
  • [Cites] N Engl J Med. 2007 Jul 12;357(2):115-23 [17625123.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1437-42 [17627009.001]
  • [Cites] J Clin Oncol. 2007 Sep 20;25(27):4210-6 [17878475.001]
  • [Cites] J Clin Oncol. 2008 Jul 10;26(20):3324-30 [18612148.001]
  • [Cites] Cancer Detect Prev. 2008;32(2):156-61 [18632223.001]
  • [Cites] Cancer. 2001 May 15;91(10):1845-53 [11346865.001]
  • (PMID = 19190627.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2653740
  •  go-up   go-down


59. Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J: Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer. Clin Cancer Res; 2007 Dec 15;13(24):7305-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found that the presence/absence of the estrogen receptor (ER) may play a crucial role in driving tumor development through distinct genomic pathways independently of the tumor type (sporadic or familial) and mutation status (BRCA1 or BRCA2).
  • [MeSH-major] Breast Neoplasms / genetics. Breast Neoplasms / metabolism. Genes, BRCA1. Genes, BRCA2. Genomic Instability. Receptors, Estrogen / metabolism
  • [MeSH-minor] Chromosomes, Artificial, Bacterial. Female. Genetic Predisposition to Disease. Humans. Mutation. Nucleic Acid Hybridization


60. Homaei-Shandiz F, Ghavam-Nassiri MR, Sharifi N, Homaei-Shandiz AH, Taghizadeh-Kermani A, Torshizi SA, Ghafarzadegan K: Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J; 2006 Dec;27(12):1810-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Breast Neoplasms / pathology. Gene Amplification. Gene Expression Regulation, Neoplastic / genetics. Receptor, ErbB-2 / genetics


61. Yazici AC, Unal S, Ikizoglu G, Kokturk A, Baz K, Cinel L, Koca A: Superficial basal cell carcinoma of the scalp mimicking seborrhoeic dermatitis. Scand J Plast Reconstr Surg Hand Surg; 2006;40(1):54-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Superficial basal cell carcinoma of the scalp mimicking seborrhoeic dermatitis.
  • Superficial basal cell carcinomas (BCC) comprise 9% to 11% of BCC, and are commonly found on the trunk or limbs.

  • MedlinePlus Health Information. consumer health - Dandruff, Cradle Cap, and Other Scalp Conditions.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16428215.001).
  • [ISSN] 0284-4311
  • [Journal-full-title] Scandinavian journal of plastic and reconstructive surgery and hand surgery
  • [ISO-abbreviation] Scand J Plast Reconstr Surg Hand Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


62. Lynch KH, Seed KD, Stothard P, Dennis JJ: Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions. J Virol; 2010 Feb;84(3):1276-88
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Burkholderia cepacia complex (BCC) is made up of at least 17 species of gram-negative opportunistic bacterial pathogens that cause fatal infections in patients with cystic fibrosis and chronic granulomatous disease.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 2003 Jul;49(2):277-300 [12886937.001]
  • [Cites] Protein Sci. 2003 Aug;12(8):1652-62 [12876315.001]
  • [Cites] J Mol Biol. 2004 Jun 25;340(1):49-65 [15184022.001]
  • [Cites] Mol Cell. 2004 Oct 8;16(1):11-21 [15469818.001]
  • [Cites] J Clin Microbiol. 1975 May;1(5):425-8 [1176612.001]
  • [Cites] J Bacteriol. 1976 Oct;128(1):242-7 [135755.001]
  • [Cites] Microbiol Rev. 1978 Jun;42(2):385-413 [353481.001]
  • [Cites] J Pediatr. 1984 Feb;104(2):206-10 [6420530.001]
  • [Cites] Appl Environ Microbiol. 1990 May;56(5):1279-85 [2339883.001]
  • [Cites] Lancet. 1993 Jul 3;342(8862):15-9 [7686239.001]
  • [Cites] Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 [9254694.001]
  • [Cites] Nucleic Acids Res. 1998 Feb 15;26(4):1107-15 [9461475.001]
  • [Cites] Appl Environ Microbiol. 1998 Jul;64(7):2710-5 [9647854.001]
  • [Cites] Biotechniques. 1998 Nov;25(5):772-4, 776 [9821576.001]
  • [Cites] Curr Opin Genet Dev. 2004 Dec;14(6):609-15 [15531154.001]
  • [Cites] Bioinformatics. 2005 Aug 15;21(16):3422-3 [15976072.001]
  • [Cites] FEMS Microbiol Lett. 2005 Oct 15;251(2):273-80 [16140471.001]
  • [Cites] J Biol Chem. 2005 Nov 4;280(44):36912-9 [16115872.001]
  • [Cites] J Bacteriol. 2006 Mar;188(6):2073-80 [16513737.001]
  • [Cites] Int J Antimicrob Agents. 2007 Aug;30(2):118-28 [17566713.001]
  • [Cites] Curr Opin Microbiol. 2007 Aug;10(4):410-7 [17719265.001]
  • [Cites] Infect Immun. 2008 Mar;76(3):1267-75 [18195031.001]
  • [Cites] Bioinformatics. 2008 Aug 1;24(15):1662-8 [18474507.001]
  • [Cites] Mol Microbiol. 2008 Oct;70(2):341-51 [18713319.001]
  • [Cites] Antimicrob Agents Chemother. 2009 May;53(5):2205-8 [19223640.001]
  • [Cites] J Biol Chem. 2009 Aug 7;284(32):21738-51 [19525227.001]
  • [Cites] J Clin Microbiol. 2000 Feb;38(2):910-3 [10655415.001]
  • [Cites] Trends Microbiol. 2000 Mar;8(3):120-8 [10707065.001]
  • [Cites] J Theor Biol. 2001 Jan 7;208(1):37-48 [11162051.001]
  • [Cites] Appl Environ Microbiol. 2001 Jun;67(6):2790-8 [11375196.001]
  • [Cites] Arch Virol. 2001;146(5):843-57 [11448025.001]
  • [Cites] Infect Immun. 2002 Jan;70(1):204-10 [11748184.001]
  • [Cites] Emerg Infect Dis. 2002 Feb;8(2):181-7 [11897071.001]
  • [Cites] J Bacteriol. 2002 Jul;184(14):4003-17 [12081973.001]
  • [Cites] Thorax. 2002 Sep;57(9):756-8 [12200517.001]
  • [Cites] Trends Microbiol. 2002 Nov;10(11):521-9 [12419617.001]
  • [Cites] Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents [12626685.001]
  • [Cites] Nat Rev Drug Discov. 2003 Jun;2(6):489-97 [12776223.001]
  • [Cites] J Clin Microbiol. 2003 Jun;41(6):2797-8 [12791937.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] FEMS Microbiol Lett. 2003 Jun 27;223(2):259-65 [12829296.001]
  • [Cites] J Bacteriol. 2004 Jun;186(12):3938-50 [15175308.001]
  • (PMID = 19939932.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Repressor Proteins
  • [Other-IDs] NLM/ PMC2812329
  •  go-up   go-down


63. Laird BB, Davidchack RL: Direct calculation of the crystal-melt interfacial free energy via molecular dynamics computer simulation. J Phys Chem B; 2005 Sep 29;109(38):17802-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The calculation is sufficiently precise to resolve the small anisotropy in gamma, which is crucial in determining the kinetics and morphology of dendritic growth.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16853283.001).
  • [ISSN] 1520-6106
  • [Journal-full-title] The journal of physical chemistry. B
  • [ISO-abbreviation] J Phys Chem B
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Rudolph J, Berl J, Hamm B, Klingebiel R: Magnetic resonance imaging findings of basal cell adenoma in Curschmann-Steinert myotonic dystrophy. Acta Radiol; 2006 Mar;47(2):205-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance imaging findings of basal cell adenoma in Curschmann-Steinert myotonic dystrophy.
  • We present the magnetic resonance imaging in the unusual combination of a patient with known myotonic dystrophy and recurrent basal cell tumor.
  • [MeSH-major] Adenoma / diagnosis. Carcinoma, Basal Cell / diagnosis. Head and Neck Neoplasms / diagnosis. Magnetic Resonance Imaging. Myotonic Dystrophy / pathology

  • Genetic Alliance. consumer health - Myotonic dystrophy.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16604969.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


65. Riemann L, Leitet C, Pommier T, Simu K, Holmfeldt K, Larsson U, Hagström A: The native bacterioplankton community in the central baltic sea is influenced by freshwater bacterial species. Appl Environ Microbiol; 2008 Jan;74(2):503-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The native bacterioplankton community in the central baltic sea is influenced by freshwater bacterial species.
  • The Baltic Sea is one of the largest brackish environments on Earth.
  • Despite extensive knowledge about food web interactions and pelagic ecosystem functioning, information about the bacterial community composition in the Baltic Sea is scarce.
  • We hypothesized that due to the eutrophic low-salinity environment and the long water residence time (>5 years), the bacterioplankton community from the Baltic proper shows a native "brackish" composition influenced by both freshwater and marine phylotypes.
  • The bacterial community composition in surface water (3-m depth) was examined at a single station throughout a full year.
  • Denaturing gradient gel electrophoresis (DGGE) showed that the community composition changed over the year.
  • Further, it indicated that at the four extensive samplings (16S rRNA gene clone libraries and bacterial isolates from low- and high-nutrient agar plates and seawater cultures), different bacterial assemblages associated with different environmental conditions were present.
  • Overall, the sequencing of 26 DGGE bands, 160 clones, 209 plate isolates, and 9 dilution culture isolates showed that the bacterial assemblage in surface waters of the central Baltic Sea was dominated by Bacteroidetes but exhibited a pronounced influence of typical freshwater phylogenetic groups within Actinobacteria, Verrucomicrobia, and Betaproteobacteria and a lack of typical marine taxa.
  • This first comprehensive analysis of bacterial community composition in the central Baltic Sea points to the existence of an autochthonous estuarine community uniquely adapted to the environmental conditions prevailing in this brackish environment.
  • [MeSH-major] Bacteria / growth & development. Fresh Water / microbiology. Plankton / growth & development. Seawater / microbiology
  • [MeSH-minor] Actinobacteria / classification. Actinobacteria / genetics. Actinobacteria / growth & development. Animals. Bacteroidetes / classification. Bacteroidetes / genetics. Bacteroidetes / growth & development. Betaproteobacteria / classification. Betaproteobacteria / genetics. Betaproteobacteria / growth & development. Ecosystem. Molecular Sequence Data. Phylogeny. Polymerase Chain Reaction. RNA, Ribosomal, 16S / genetics. Sequence Analysis, DNA

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Environ Microbiol. 2003 Oct;69(10):5875-83 [14532039.001]
  • [Cites] Appl Environ Microbiol. 2003 Sep;69(9):5248-54 [12957910.001]
  • [Cites] Appl Environ Microbiol. 2003 Nov;69(11):6610-9 [14602620.001]
  • [Cites] Environ Microbiol. 2004 Mar;6(3):242-53 [14871208.001]
  • [Cites] Appl Environ Microbiol. 2004 Mar;70(3):1494-505 [15006771.001]
  • [Cites] Appl Environ Microbiol. 2004 Apr;70(4):2445-51 [15066843.001]
  • [Cites] Nature. 2004 Jul 29;430(6999):551-4 [15282603.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Oct;82(20):6955-9 [2413450.001]
  • [Cites] J Bacteriol. 1991 Jul;173(14):4371-8 [2066334.001]
  • [Cites] Appl Environ Microbiol. 1997 Mar;63(3):983-9 [9055415.001]
  • [Cites] Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 [9254694.001]
  • [Cites] Appl Environ Microbiol. 2000 Feb;66(2):578-87 [10653721.001]
  • [Cites] Science. 2000 Sep 15;289(5486):1902-6 [10988064.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):4634-40 [11055904.001]
  • [Cites] Appl Environ Microbiol. 2000 Nov;66(11):5053-65 [11055963.001]
  • [Cites] Nucleic Acids Res. 2001 Jan 1;29(1):173-4 [11125082.001]
  • [Cites] Appl Environ Microbiol. 2002 Jan;68(1):379-88 [11772648.001]
  • [Cites] Appl Environ Microbiol. 2002 Feb;68(2):505-18 [11823184.001]
  • [Cites] Appl Environ Microbiol. 2002 Aug;68(8):3878-85 [12147485.001]
  • [Cites] Appl Environ Microbiol. 2003 Mar;69(3):1442-51 [12620827.001]
  • [Cites] Appl Environ Microbiol. 2003 Jun;69(6):3607-16 [12788769.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3497-500 [12824352.001]
  • [Cites] Appl Environ Microbiol. 1997 Sep;63(9):3359-66 [9292985.001]
  • [Cites] Appl Environ Microbiol. 1997 Nov;63(11):4237-42 [9361410.001]
  • [Cites] Genome Res. 1998 Mar;8(3):186-94 [9521922.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3807-12 [10097119.001]
  • [Cites] Appl Environ Microbiol. 1999 Jul;65(7):3192-204 [10388721.001]
  • [Cites] Appl Environ Microbiol. 1999 Aug;65(8):3721-6 [10427073.001]
  • [Cites] Appl Environ Microbiol. 2004 Nov;70(11):6753-66 [15528542.001]
  • [Cites] Appl Environ Microbiol. 2005 Aug;71(8):4793-800 [16085877.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8201-6 [16332803.001]
  • [Cites] Appl Environ Microbiol. 2005 Dec;71(12):8402-10 [16332828.001]
  • [Cites] Appl Environ Microbiol. 2006 May;72(5):3489-97 [16672495.001]
  • [Cites] Trends Microbiol. 2006 Jun;14(6):257-63 [16679014.001]
  • [Cites] Ecology. 2006 Aug;87(8):2068-79 [16937646.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13104-9 [16938845.001]
  • [Cites] Appl Environ Microbiol. 2006 Sep;72(9):5734-41 [16957188.001]
  • [Cites] Appl Environ Microbiol. 2006 Sep;72(9):6004-11 [16957222.001]
  • [Cites] Mol Ecol. 2007 Feb;16(4):867-80 [17284217.001]
  • [Cites] Environ Microbiol. 2007 May;9(5):1253-66 [17472638.001]
  • [Cites] Appl Environ Microbiol. 2003 Nov;69(11):6481-8 [14602603.001]
  • (PMID = 18039821.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AY962019/ AY962020/ AY962021/ DQ063002/ DQ063003/ DQ063004/ DQ063005/ DQ063006/ DQ063007/ DQ063008/ DQ063009/ DQ063010/ DQ063011/ DQ063012/ DQ063013/ DQ063014/ DQ063015/ DQ063016/ DQ063017/ DQ063018/ DQ063019/ DQ063020/ DQ063021/ DQ063022/ DQ063023/ DQ063024/ DQ063025/ DQ063026/ DQ063027/ DQ063028/ DQ063029/ DQ063030/ DQ063031/ DQ063032/ DQ063033/ DQ063034/ DQ063035/ DQ063036/ DQ063037/ DQ063038/ DQ063039/ DQ063040/ DQ063041/ DQ063042/ DQ063043/ DQ063044/ DQ063045/ DQ063046/ DQ063047/ DQ063048/ DQ063049/ DQ063050/ DQ063051/ DQ063052/ DQ063053/ DQ063054/ DQ063055/ DQ063056/ DQ063057/ DQ063058/ DQ063059/ DQ063060/ DQ063061/ DQ063062/ DQ063063/ DQ063064/ DQ063065/ DQ063066/ DQ063067/ DQ063068/ DQ063069/ DQ063070/ DQ063071/ DQ063072/ DQ063073/ DQ063101/ DQ063102/ DQ063103/ DQ063104/ DQ063105/ DQ063106/ DQ063107/ DQ063108/ DQ063109/ DQ063110/ DQ063111/ DQ063112/ DQ063113/ DQ063114/ DQ063115/ DQ063116/ DQ063117/ DQ063118/ DQ063119/ DQ063120/ DQ063121/ DQ063122/ DQ063123/ DQ063124/ DQ063125/ DQ063126/ DQ063127/ DQ063128/ DQ063129/ DQ063130/ DQ063131/ DQ063132/ DQ063133/ DQ063134/ DQ063135/ DQ063136/ DQ063137/ DQ063138/ DQ063139/ DQ063140/ DQ063141/ DQ063142/ DQ063143/ DQ063144/ DQ063145/ DQ063146/ DQ063147/ DQ063148/ DQ063149/ DQ063150/ DQ063151/ DQ063152/ DQ063153/ DQ063154/ DQ063155/ DQ063156/ DQ063157/ DQ063158/ DQ063159/ DQ063160/ DQ063161/ DQ063162/ DQ063163/ DQ063164/ DQ063165/ DQ063166/ DQ063167/ DQ063168/ DQ063169/ DQ063170/ DQ063171/ DQ063172/ DQ063173/ DQ063174/ DQ063175/ DQ063176/ DQ063177/ DQ063178/ DQ063179/ DQ063180/ DQ063181/ DQ063182/ DQ063183/ DQ063184/ DQ063185/ DQ063186/ DQ063187/ DQ063188/ DQ063189/ DQ063190/ DQ063191/ DQ063192/ DQ063193/ DQ063194/ DQ063195/ DQ063196/ DQ063197/ DQ063198/ DQ063199/ DQ063200/ DQ063201/ DQ063202/ DQ063203/ DQ063204/ DQ063205/ DQ063206/ DQ063207/ DQ063208/ DQ063209/ DQ063210/ DQ063211/ DQ063212/ DQ063213/ DQ063214/ DQ063215/ DQ063216/ DQ270271/ DQ270272/ DQ270273/ DQ270274/ DQ270275/ DQ270276/ DQ270277/ DQ270278/ DQ270279/ DQ270280/ DQ270281/ DQ270282/ DQ270283/ DQ270284/ DQ270285/ DQ270286/ DQ270287/ DQ270288/ DQ270289/ DQ270290/ DQ270291/ DQ270292/ DQ270293/ DQ270294/ DQ270295/ DQ270296/ EF627821/ EF627822/ EF627823/ EF627824/ EF627825/ EF627826/ EF627827/ EF627828/ EF627829/ EF627830/ EF627831/ EF627832/ EF627833/ EF627834/ EF627835/ EF627836/ EF627837/ EF627838/ EF627839/ EF627840/ EF627841/ EF627842/ EF627843/ EF627844/ EF627845/ EF627846/ EF627847/ EF627848/ EF627849/ EF627850/ EF627851/ EF627852/ EF627853/ EF627854/ EF627855/ EF627856/ EF627857/ EF627858/ EF627859/ EF627860/ EF627861/ EF627862/ EF627863/ EF627864/ EF627865/ EF627866/ EF627867/ EF627868/ EF627869/ EF627870/ EF627871/ EF627872/ EF627873/ EF627874/ EF627875/ EF627876/ EF627877/ EF627878/ EF627879/ EF627880/ EF627881/ EF627882/ EF627883/ EF627884/ EF627885/ EF627886/ EF627887/ EF627888/ EF627889/ EF627890/ EF627891/ EF627892/ EF627893/ EF627894/ EF627895/ EF627896/ EF627897/ EF627898/ EF627899/ EF627900/ EF627901/ EF627902/ EF627903/ EF627904/ EF627905/ EF627906/ EF627907/ EF627908/ EF627909/ EF627910/ EF627911/ EF627912/ EF627913/ EF627914/ EF627915/ EF627916/ EF627917/ EF627918/ EF627919/ EF627920/ EF627921/ EF627922/ EF627923/ EF627924/ EF627925/ EF627926/ EF627927/ EF627928/ EF627929/ EF627930/ EF627931/ EF627932/ EF627933/ EF627934/ EF627935/ EF627936/ EF627937/ EF627938/ EF627939/ EF627940/ EF627941/ EF627942/ EF627943/ EF627944/ EF627945/ EF627946/ EF627947/ EF627948/ EF627949/ EF627950/ EF627951/ EF627952/ EF627953/ EF627954/ EF627955/ EF627956/ EF627957/ EF627958/ EF627959/ EF627960/ EF627961/ EF627962/ EF627963/ EF627964/ EF627965/ EF627966/ EF627967/ EF627968/ EF627969/ EF627970/ EF627971
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC2223248
  •  go-up   go-down


66. Carydis VB, Walker T, Wing A, Colgan TJ: Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions. Acta Cytol; 2007 Jul-Aug;51(4):517-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To examine whether p16(ink4a) immunocytochemical (ICC) expression detected intraepithelial disease in liquid-based cytology (LBC) specimens from women with high-grade squamous intraepithelial lesions (HSIL), whose specimen was labeled negative for intraepithelial lesion or malignany (NILM).
  • STUDY DESIGN: Residual LBC specimens from women treated for HSIL (n = 21), whose LBC test was interpreted as NILM including marked benign inflammatory changes (BCC) were used.
  • In the NILM/BCC group, 2 of 21 with adequate LBC residua were ICC p16(ink4a) positive; on review both were reclassified as epithelial abnormality--1 HSIL and 1 atypical squamous cells cannot exclude HSIL.
  • [MeSH-major] Cervical Intraepithelial Neoplasia / metabolism. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Neoplasms, Squamous Cell / metabolism. Uterine Cervical Neoplasms / metabolism. Vaginal Smears


67. Wagoner J, Keehn C, Morgan MB: CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma. Am J Dermatopathol; 2007 Dec;29(6):555-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
  • Basal cell carcinoma and squamous cell carcinoma are common entities in clinical practice.
  • We sought to determine if the CD10 immunostain could have diagnostic utility in distinguishing between early superficial basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
  • CD10 was negative in the tumor cells in 13 out of 13 superficially invasive SCCs and SCC in situ.
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinoma in Situ / diagnosis. Carcinoma, Basal Cell / diagnosis. Carcinoma, Squamous Cell / diagnosis. Neprilysin / analysis. Skin Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18032951.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


68. Oven Ustaalioglu BB, Bilici A, Kefeli U, Seker M, Yildirim E, Salepci T, Oncel M, Kement M, Gumus M: Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oncology; 2010;79(1-2):105-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
  • In the current study, we evaluated whether the metastatic lymph node ratio (n ratio) is important in predicting disease-free survival (DFS) for breast cancer patients.
  • [MeSH-major] Breast Neoplasms / mortality. Breast Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Axilla. Biomarkers, Tumor / analysis. Disease-Free Survival. Female. Humans. Inflammatory Breast Neoplasms / mortality. Inflammatory Breast Neoplasms / pathology. Kaplan-Meier Estimate. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Necrosis. Neoadjuvant Therapy / methods. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prognosis. Proportional Hazards Models. Retrospective Studies. Risk Assessment. Risk Factors

  • Genetic Alliance. consumer health - Breast Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 S. Karger AG, Basel.
  • (PMID = 21088436.001).
  • [ISSN] 1423-0232
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


69. Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, Feldman MD, Brose MS: Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther; 2009 May;8(10):907-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC).
  • To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs).
  • We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH).
  • CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20).
  • [MeSH-major] Breast Neoplasms / genetics. Head and Neck Neoplasms / genetics. Lung Neoplasms / genetics. Membrane Proteins / genetics. Skin Neoplasms / genetics
  • [MeSH-minor] Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Case-Control Studies. Chromosome Deletion. Comparative Genomic Hybridization. DNA, Neoplasm / analysis. Female. Gene Dosage. Gene Expression. Humans. Loss of Heterozygosity. Mouth Neoplasms / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism


70. Lee B, Lim A, Lalvani A, Descamps MJ, Leonard R, Nallamala S, Lewis JS, Coombes RC, Stebbing J: The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. Ann Oncol; 2008 Dec;19(12):2001-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Those in whom indeterminate pulmonary nodules are visualized without the presence of other metastatic lesions represent a clinical dilemma regarding their management as early breast cancer or metastatic disease.
  • Those with obvious metastatic disease were excluded.
  • CONCLUSIONS: Breast cancer cases with subcentimeter indeterminate pulmonary lesions and no evidence of metastases elsewhere are unlikely to represent metastatic disease.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1992 Nov;10(11):1810-6 [1403062.001]
  • [Cites] Surgery. 1984 Oct;96(4):801-5 [6484816.001]
  • [Cites] Radiology. 2005 Nov;237(2):395-400 [16244247.001]
  • [Cites] Thorax. 2006 Apr;61(4):331-6 [16467070.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2694-6 [16702578.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2743-9 [16702580.001]
  • [Cites] Clin Evid. 2006 Jun;(15):2331-59 [16973089.001]
  • [Cites] Clin Evid. 2006 Jun;(15):2360-92 [16973090.001]
  • [Cites] J Clin Oncol. 2006 Oct 20;24(30):4793-5 [17050863.001]
  • [Cites] J Clin Oncol. 2006 Oct 20;24(30):4801-7 [17050865.001]
  • [Cites] Lancet. 2007 Feb 17;369(9561):559-70 [17307102.001]
  • [Cites] J Clin Oncol. 2007 Apr 10;25(11):1454-5 [17416872.001]
  • [Cites] Thorac Surg Clin. 2007 May;17(2):143-58 [17626393.001]
  • [Cites] Chest. 2007 Sep;132(3 Suppl):108S-130S [17873164.001]
  • [Cites] Chest. 2007 Dec;132(6):1939-48 [18079227.001]
  • [Cites] Radiol Clin North Am. 2000 May;38(3):511-24 [10855258.001]
  • [Cites] Lancet. 2000 Aug 12;356(9229):590-1; author reply 593 [10950250.001]
  • [Cites] J Thorac Imaging. 2001 Jan;16(1):65-8 [11149694.001]
  • [Cites] JAMA. 2001 Feb 21;285(7):914-24 [11180735.001]
  • [Cites] Radiol Clin North Am. 2001 Nov;39(6):1115-35 [11699664.001]
  • [Cites] Lung Cancer. 2002 Feb;35(2):143-8 [11804686.001]
  • [Cites] N Engl J Med. 2004 Mar 11;350(11):1081-92 [15014181.001]
  • [Cites] Radiology. 2004 Apr;231(1):164-8 [14990809.001]
  • [Cites] Chest. 2004 Apr;125(4):1522-9 [15078769.001]
  • [Cites] J Thorac Imaging. 1994 Spring;9(2):129-34 [8207780.001]
  • (PMID = 18641008.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2733112
  •  go-up   go-down


71. Sanguinetti A, Ragusa M, De Falco M, Sperlongano P, Calzolari F, Parmeggiani D, Misso C, Piatto A, Parmeggiani U, Avenia N: [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?]. Chir Ital; 2007 Nov-Dec;59(6):829-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, for organizational and social reasons, the incidence of locally advanced neoplasms is higher in this age group than in the younger population.
  • Eight of the 34 patients discharged died within 24 months (2 of disease progression).
  • 10 of the 26 patients (38.4%) surviving over 2 years underwent redo surgery for local relapse of disease.
  • 2) disease management cannot be standardized, but must be tailored to the single patient;.
  • [MeSH-major] Breast Neoplasms / surgery. Mastectomy, Modified Radical
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Antineoplastic Agents, Hormonal / therapeutic use. Breast / pathology. Female. Follow-Up Studies. Humans. Infant, Newborn. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Reoperation. Tamoxifen / therapeutic use. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18360988.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 094ZI81Y45 / Tamoxifen
  •  go-up   go-down


72. Palmero EI, Ashton-Prolla P, da Rocha JC, Vargas FR, Kalakun L, Blom MB, Azevedo SJ, Caleffi M, Giugliani R, Schüler-Faccini L: Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil. J Genet Couns; 2007 Jun;16(3):363-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] BRCA2 Protein / genetics. Breast Neoplasms / genetics. Genetic Counseling / statistics & numerical data. Genetic Testing / statistics & numerical data. Neoplastic Syndromes, Hereditary / genetics. Ubiquitin-Protein Ligases / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Apoptosis Regulatory Proteins. Brazil. Cross-Sectional Studies. DNA Mutational Analysis. Female. Heterozygote Detection. Humans. Middle Aged. Ovarian Neoplasms / epidemiology. Ovarian Neoplasms / genetics. Probability. Risk. Risk Assessment. Socioeconomic Factors


73. Suda W, Nagasaki A, Shishido M: Powdery mildew-infection changes bacterial community composition in the phyllosphere. Microbes Environ; 2009;24(3):217-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate changes in bacterial communities associated with a fungal foliar disease, epiphytic bacteria from powdery mildew-infected and uninfected leaves of cucumber and Japanese spindle were analyzed using both culture-dependent and -independent methods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21566376.001).
  • [ISSN] 1342-6311
  • [Journal-full-title] Microbes and environments
  • [ISO-abbreviation] Microbes Environ.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


74. Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, Adamo B, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G: BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol; 2006 Jun;17 Suppl 7:vii34-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multistep process caused by interactions of both genetic and non-genetic factors.


75. Zhu ZY, Zhang HW, Xu SF, Chen JL, Wu GH, Zhang B, Zhang XX: Intrinsic anisotropy of degree of transport spin polarization in typical ferromagnets. J Phys Condens Matter; 2008 Jul 9;20(27):275245
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrinsic anisotropy of degree of transport spin polarization in typical ferromagnets.
  • A general approach is presented for investigation of the anisotropy of the degree of transport spin polarization (P) in ferromagnets both in the ballistic regime, P(1,i), and in the diffusive regime, P(2,i), as a function of crystal direction.
  • The validity of this approach is confirmed by the benchmark calculation for the isotropic P.
  • By this approach, we have investigated the anisotropy of P in bcc Fe, fcc Co, fcc Ni and hcp Co.
  • For cubic structures, P(1,i) shows a small but appreciable anisotropy, due to the difference in the electronic orbital extension for spin-up and spin-down conduction bands.
  • However, P(2,i) shows an isotropic feature for the cubic structure, as a result of the combination of its dependence on the square of electron velocity and the lattice symmetry.
  • On the other hand, for hcp Co, both P(1,i) and P(2,i) show a very strong anisotropy.
  • The large anisotropy of P(1,i) and P(2,i) in hcp Co is mainly attributed to the anisotropy of spin-down ballistic (diffusive) conductance.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21694406.001).
  • [ISSN] 0953-8984
  • [Journal-full-title] Journal of physics. Condensed matter : an Institute of Physics journal
  • [ISO-abbreviation] J Phys Condens Matter
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


76. Ahlgrimm-Siess V, Horn M, Koller S, Ludwig R, Gerger A, Hofmann-Wellenhof R: Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: a preliminary study. J Dermatol Sci; 2009 Jan;53(1):60-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: a preliminary study.
  • Non-invasive treatment modalities, such as cryotherapy have been employed for sBCCs, all failing to provide tissue for confirming diagnosis and assessing adequacy of tumour removal.
  • Reflectance confocal microscopy (RCM), a new non-invasive imaging technique has proven to be a useful tool for detection of basal cell carcinoma in vivo.
  • Tumour clearance was assessed by RCM imaging 3 months after therapy followed by histopathologic examination.
  • Five hours after cryotherapy, all 10 sBCCs showed small bright round to polygonal structures at basal layer and black round to oval areas of varying size with such bright structures floating therein, correlating to cell necrosis and incipient blistering.
  • Eight sBCCs showed also cell necrosis in upper dermis.
  • Tumour clearance on later histopathologic examination was only proven in those lesions showing damage to the upper dermis after 5h with RCM.
  • CONCLUSION: Early cell necrosis within upper dermal structures seems to correlate with ablation of overlying tumour tissue.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Carcinoma, Basal Cell / therapy. Cryotherapy / methods. Microscopy, Confocal. Skin Neoplasms / pathology. Skin Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18829267.001).
  • [ISSN] 0923-1811
  • [Journal-full-title] Journal of dermatological science
  • [ISO-abbreviation] J. Dermatol. Sci.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


77. Ellis NA, Kirchhoff T, Mitra N, Ye TZ, Chuai S, Huang H, Nafa K, Norton L, Neuhausen S, Gordon D, Struewing JP, Narod S, Offit K: Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol; 2006 Jan;30(1):48-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the feasibility of a novel approach to localize breast cancer susceptibility genes, using a low-density genome-wide panel of single-nucleotide polymorphisms and taking advantage of large regions of linkage disequilibrium (LD) flanking Jewish disease genes in high-risk cases.
  • With Affymetrix GeneChip arrays, we genotyped 8,576 polymorphisms in three sets of Ashkenazi Jewish breast cancer cases: a "validation" set of 27 breast cancer cases, all of whom carried the BRCA2*6174delT founder mutation; a "field" set of 19 breast cancer cases from male breast cancer kindreds, which simulated conditions for finding new genes; and a "test" set of 57 probands from breast cancer kindreds (4 or more cases/kindred), in which mutations in BRCA1 and BRCA2 had been excluded.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16206141.001).
  • [ISSN] 0741-0395
  • [Journal-full-title] Genetic epidemiology
  • [ISO-abbreviation] Genet. Epidemiol.
  • [Language] ENG
  • [Grant] United States / NHGRI NIH HHS / HG / K01-HG-00055; United States / NCI NIH HHS / CA / CA 103394; United States / NHLBI NIH HHS / HL / R01-HL56778; United States / NCI NIH HHS / CA / R03 CA103500-02; United States / NCI NIH HHS / CA / R03 CA103500; United States / NCI NIH HHS / CA / CA103500-02; United States / NIMH NIH HHS / MH / MH44292
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


78. Shibuta Y, Suzuki T: A molecular dynamics study of the phase transition in bcc metal nanoparticles. J Chem Phys; 2008 Oct 14;129(14):144102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On the other hand, the depression of the nucleation temperature during cooling was not monotonic with respect to the particle radius since the nucleation from an undercooled liquid depends on the event probability of an embryo or a nucleus.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19045129.001).
  • [ISSN] 1089-7690
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Hirt RA, Vondrakova K, de Arespacochaga AG, Gütl A, van den Hoven R: Effects of cadmium chloride inhalation on airflow limitation to histamine, carbachol and adenosine 5'-monophosphate assessed by barometric whole body plethysmography in healthy dogs. Vet J; 2007 Jan;173(1):62-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of cadmium chloride inhalation on airflow limitation to histamine, carbachol and adenosine 5'-monophosphate assessed by barometric whole body plethysmography in healthy dogs.
  • The effects of pharmacological bronchoprovocation on airflow patterns and surrogate respiratory parameters assessed by barometric whole body plethysmography (BWBP) were investigated in healthy dogs, previously exposed to cadmium chloride inhalation.
  • BWBP-derived respiratory variables were calculated (1) at baseline and (2) following nebulisation of increasing concentrations of histamine, carbachol and adenosine 5'-monophosphate (AMP) until enhanced pause (PENH) increased to 300% of baseline (PCPENH300).
  • Bronchoalveolar lavage fluid (BALF) cytology before (BCC) and after (ACC) cadmium chloride inhalation revealed cadmium-induced airway inflammation.
  • Neutrophils increased from 6.7 +/- 7.3% (728 +/- 104/microL) BCC to 77.8 +/- 8.6% (3255 +/- 1407/microL) ACC.
  • PCPENH300 for all three agonists significantly decreased ACC (means+/-SD) as follows: PCPENH300(histamine) 0.72 +/- 0.28 mg/mL BCC, and 0.35 +/- 0.31 mg/mL ACC (P<0.02); PCPENH300(carbachol) 0.34 +/- 0.16 mg/mL BCC, and 0.064 +/- 0.032 mg/mL ACC (P<0.02); PCPENH300(AMP) 1000 mg/mL BCC, and 415 +/- 398 mg/mL ACC (P<0.03).
  • The only clinical sign shown was coughing.
  • It was concluded that airway hyperresponsiveness after induced airway inflammation can be determined by BWBP in conscious small sized dogs.
  • BWBP could be a suitable technique to study the respiratory effects of urban environmental pollution in pets.
  • [MeSH-major] Adenosine Monophosphate / toxicity. Cadmium Chloride / administration & dosage. Cadmium Chloride / toxicity. Carbachol / toxicity. Health. Histamine / toxicity. Plethysmography, Whole Body / veterinary
  • [MeSH-minor] Administration, Inhalation. Animals. Bronchial Spasm / chemically induced. Bronchial Spasm / veterinary. Dogs. Female. Inflammation / chemically induced. Inflammation / veterinary. Male

  • Hazardous Substances Data Bank. CADMIUM CHLORIDE .
  • Hazardous Substances Data Bank. HISTAMINE .
  • Hazardous Substances Data Bank. CARBACHOL CHLORIDE .
  • Hazardous Substances Data Bank. ADENOSINE 5'-PHOSPHATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16314130.001).
  • [ISSN] 1090-0233
  • [Journal-full-title] Veterinary journal (London, England : 1997)
  • [ISO-abbreviation] Vet. J.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 415SHH325A / Adenosine Monophosphate; 820484N8I3 / Histamine; 8Y164V895Y / Carbachol; J6K4F9V3BA / Cadmium Chloride
  •  go-up   go-down


80. Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG: The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat; 2008 Dec;112(3):569-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Genes, BRCA1. Genes, BRCA2. Mutation. Protein-Serine-Threonine Kinases / genetics

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18175216.001).
  • [ISSN] 1573-7217
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 2.7.1.11 / Checkpoint Kinase 2; EC 2.7.11.1 / CHEK2 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


81. Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH: CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res; 2009 Aug 1;69(15):6158-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Due to the inverse relationship between tumor surveillance and autoimmunity, we hypothesize that the same genetic variant in the CTLA4 locus that increases risk for autoimmune diseases is associated with decreased risk of non-melanoma skin cancer (NMSC).
  • We analyzed whether the polymorphism CT60 or haplotypes of CTLA4 influence odds of developing the major types of NMSC, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), in a population-based case-control study of Caucasians in New Hampshire (849 controls, 930 BCC, and 713 SCC).
  • There were significantly decreased odds of disease associated with two haplotypes, which possess the CT60 G allele.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Immunol. 1977 Jun 1;31(1):182-7 [872221.001]
  • [Cites] J Natl Cancer Inst. 1976 Jul;57(1):211-5 [1003502.001]
  • [Cites] Immunology. 1981 Jul;43(3):527-33 [7251064.001]
  • [Cites] J Invest Dermatol. 1991 Oct;97(4):729-34 [1940446.001]
  • [Cites] Int J Cancer. 1999 May 17;81(4):555-9 [10225444.001]
  • [Cites] J Natl Cancer Inst. 1999 Jun 2;91(11):911-3 [10359543.001]
  • [Cites] Annu Rev Immunol. 2005;23:515-48 [15771580.001]
  • [Cites] Immunol Rev. 2005 Apr;204:102-15 [15790353.001]
  • [Cites] Eur J Immunol. 2005 Jul;35(7):2157-62 [15940668.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Mar;165(2):114-20 [16527605.001]
  • [Cites] J Clin Oncol. 2006 Jul 20;24(21):3483-9 [16849765.001]
  • [Cites] Immunol Rev. 2006 Aug;212:131-48 [16903911.001]
  • [Cites] Carcinogenesis. 2008 Oct;29(10):1950-4 [18641401.001]
  • [Cites] Hum Immunol. 2007 Aug;68(8):698-704 [17678726.001]
  • [Cites] J Immunol. 1999 Dec 15;163(12):6725-31 [10586070.001]
  • [Cites] J Exp Med. 2000 Jul 17;192(2):303-10 [10899917.001]
  • [Cites] J Immunol. 2000 Aug 15;165(4):1824-31 [10925260.001]
  • [Cites] Nature. 2003 May 29;423(6939):506-11 [12724780.001]
  • [Cites] J Natl Cancer Inst. 1974 Nov;53(5):1333-6 [4139281.001]
  • [Cites] Adv Exp Med Biol. 1976;66:445-9 [1266675.001]
  • [Cites] Cell Immunol. 1978 Jun;38(1):105-15 [667953.001]
  • (PMID = 19622768.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA057494; United States / NCI NIH HHS / CA / R01 CA057494; United States / NCI NIH HHS / CA / CA08235; United States / NCI NIH HHS / CA / R01 CA057494-16; United States / NCI NIH HHS / CA / R01 CA082354
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CTLA-4 Antigen; 0 / CTLA4 protein, human
  • [Other-IDs] NLM/ NIHMS216796; NLM/ PMC2928067
  •  go-up   go-down


82. van der Pols JC, Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC: Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study. Cancer Epidemiol Biomarkers Prev; 2009 Apr;18(4):1167-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Antioxidant nutrients can help prevent skin damage caused by ultraviolet radiation from sunlight, but it is not clear whether serum concentrations of such nutrients influence skin cancer risk.
  • METHODS: We carried out a prospective study of the associations between serum concentrations of antioxidant nutrients and incidence (person-based and tumor-based) of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin among a random subsample of 485 adults from an Australian community.
  • RESULTS: Although there were no associations between baseline serum carotenoids or alpha-tocopherol concentrations and incidence of BCC or SCC, baseline serum selenium concentrations showed strong inverse associations with both BCC and SCC tumor incidence.
  • CONCLUSION: Relatively high serum selenium concentrations are associated with an approximately 60% decrease in subsequent tumor incidence of both BCC and SCC, whereas serum concentrations of carotenoids or alpha-tocopherol are not associated with later skin cancer incidence.
  • [MeSH-major] Antioxidants / metabolism. Biomarkers, Tumor / blood. Carotenoids / blood. Selenium Compounds / blood. Skin Neoplasms / epidemiology. alpha-Tocopherol / blood
  • [MeSH-minor] Aged. Australia / epidemiology. Carcinoma, Basal Cell / blood. Carcinoma, Basal Cell / epidemiology. Carcinoma, Squamous Cell / blood. Carcinoma, Squamous Cell / epidemiology. Cohort Studies. Female. Follow-Up Studies. Humans. Incidence. Longitudinal Studies. Male. Middle Aged. Prospective Studies. Risk Assessment

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SELENIUM COMPOUNDS .
  • Hazardous Substances Data Bank. VITAMIN E .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19336544.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Biomarkers, Tumor; 0 / Selenium Compounds; 36-88-4 / Carotenoids; H4N855PNZ1 / alpha-Tocopherol
  •  go-up   go-down


83. Osiecka B, Jurczyszyn K, Symonowicz K, Bronowicz A, Ostasiewicz P, Czapińska E, Hotowy K, Krzystek-Korpacka M, Gebarowska E, Izykowska I, Dziegiel P, Terlecki G, Ziółkowski P: In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester. Cell Mol Biol Lett; 2010 Dec;15(4):630-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Photodynamic therapy (PDT) is a well-known method for the treatment of malignant tumors, and its principles have been well established over the past 30 years.
  • Topical photodynamic therapy with aminolevulinic acid (5-ALA) is an alternative therapy for many malignant processes, including nonmelanoma skin cancers such as basal-cell carcinoma (BCC).
  • Our novel approach for this study was to use a liposomal formulation of 5-ALA and its methyl ester (commercially available as metvix) both in vitro and in vivo, and to check whether the liposome-entrapped precursors of photosensitizers can induce the expression of metalloproteinases (MMPs) in animal tumor cells and in other tissues from tumor-bearing rats and in selected cell lines in vitro.
  • We also checked whether the application of tissue inhibitors of matrix metalloproteinases (TIMPs) has any effect on MMPs in the above-mentioned experimental models, and if they can cause complete inhibition of MMP expression.
  • After the PDT in tumor-bearing rats, MMP-3 was expressed in the tumor cells with the highest intensity of staining in the tissues directly adjacent to the tumors, while MMP-2 and -9 were not found.
  • [MeSH-major] Aminolevulinic Acid / analogs & derivatives. Cell Line, Tumor / drug effects. Liposomes. Matrix Metalloproteinases / metabolism. Photochemotherapy / methods. Photosensitizing Agents
  • [MeSH-minor] Animals. Breast Neoplasms / drug therapy. Breast Neoplasms / enzymology. Breast Neoplasms / radiotherapy. Cell Survival / drug effects. Female. Humans. Isoenzymes / metabolism. Rats. Rats, Wistar. Tissue Distribution

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20865364.001).
  • [ISSN] 1689-1392
  • [Journal-full-title] Cellular & molecular biology letters
  • [ISO-abbreviation] Cell. Mol. Biol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Isoenzymes; 0 / Liposomes; 0 / Photosensitizing Agents; 0 / methyl 5-aminolevulinate; 88755TAZ87 / Aminolevulinic Acid; EC 3.4.24.- / Matrix Metalloproteinases
  •  go-up   go-down


84. Ramirez KS, Lauber CL, Knight R, Bradford MA, Fierer N: Consistent effects of nitrogen fertilization on soil bacterial communities in contrasting systems. Ecology; 2010 Dec;91(12):3463-70; discussion 3503-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Consistent effects of nitrogen fertilization on soil bacterial communities in contrasting systems.
  • Ecosystems worldwide are receiving increasing amounts of reactive nitrogen (N) through anthropogenic activities.
  • Although the effects of increased N inputs on plant communities have been reasonably well studied, few comparable studies have examined impacts on whole soil bacterial communities, though they play critical roles in ecosystem functioning.
  • We sampled soils from two long-term ecological research (LTER) experimental N gradients, both of which have been amended with NH4NO3; a grassland at Cedar Creek (27 years of N additions) and an agricultural field at Kellogg Biological Station (8 years of N additions).
  • By examining shifts in bacterial communities across these contrasting ecosystem types, we could test competing hypotheses about the direct and indirect factors that might drive bacterial responses to elevated N inputs.
  • Bacterial community structure was highly responsive to N additions.
  • We observed predictable and consistent changes in the structure of the bacterial communities across both ecosystem types.
  • Our results suggest that bacterial communities across these gradients are more structured by N and/or soil carbon availability than by shifts in the plant community or soil pH associated with the elevated nitrogen inputs.
  • In contrast to the pronounced shifts in bacterial community composition and in direct contrast to the patterns often observed in plant communities, increases in N availability did not have consistent effects on the richness and diversity of soil bacterial communities.
  • [MeSH-major] Bacteria / isolation & purification. Fertilizers. Nitrogen / metabolism. Soil Microbiology
  • [MeSH-minor] Ecosystem. Michigan. Minnesota. Phylogeny. RNA, Bacterial / genetics. RNA, Ribosomal, 16S / genetics

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Nitrogen, Elemental .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Ecology. 2011 Jun;92(6):1384
  • (PMID = 21302816.001).
  • [ISSN] 0012-9658
  • [Journal-full-title] Ecology
  • [ISO-abbreviation] Ecology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fertilizers; 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S; N762921K75 / Nitrogen
  •  go-up   go-down


85. Humbert JF, Dorigo U, Cecchi P, Le Berre B, Debroas D, Bouvy M: Comparison of the structure and composition of bacterial communities from temperate and tropical freshwater ecosystems. Environ Microbiol; 2009 Sep;11(9):2339-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of the structure and composition of bacterial communities from temperate and tropical freshwater ecosystems.
  • We used a partial 16S rRNA sequencing approach to compare the structure and composition of the bacterial communities in three large, deep subalpine lakes in France with those of communities in six shallow tropical reservoirs in Burkina Faso.
  • Despite the very different characteristics of these ecosystems, we found that their bacterial communities share the same composition in regard to the relative proportions of the different phyla, suggesting that freshwater environmental conditions lead to convergence in this composition.
  • In the same way, we found no significant difference in the richness and diversity of the bacterial communities in France and Burkina Faso.
  • We defined core and satellite operational taxonomic units (OTUs) (sequences sharing at least 98% identity) on the basis of their abundance and their geographical distribution.
  • The core OTUs were found either ubiquitously or only in temperate or tropical and subtropical areas, and they contained more than 70% of all the sequences retrieved in this study.
  • In contrast, satellite OTUs were characterized by having a more restricted geographical distribution and by lower abundance.
  • Finally, the bacterial community composition of these freshwater ecosystems in France and Burkina Faso was markedly different, showing that the history of these ecosystems and regional environmental parameters have a greater impact on the relative abundances of the different OTUs in each bacterial community than the local environmental conditions.
  • [MeSH-major] Bacteria / classification. Fresh Water / microbiology
  • [MeSH-minor] Biodiversity. Burkina Faso. France. Geography. Phylogeny. RNA, Ribosomal, 16S / analysis. Temperature. Tropical Climate

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19508336.001).
  • [ISSN] 1462-2920
  • [Journal-full-title] Environmental microbiology
  • [ISO-abbreviation] Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


86. Lü YL, Zhong M, Liu L, Wei LX, Zhao P: [Clinicopathologic significance of chromosome 17 polysomy in breast cancer]. Zhonghua Bing Li Xue Za Zhi; 2008 Feb;37(2):88-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Carcinoma, Ductal / genetics. Chromosome Aberrations. Chromosomes, Human, Pair 17 / genetics. Gene Amplification. Genes, erbB-2 / genetics


87. van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W: Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol; 2007 Feb;102(2):452-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects.
  • AIMS: We assessed to what extent fructans of different degrees of polymerization (DP) differ in their prebiotic effectiveness towards in vitro microbial communities from the proximal and distal colon.
  • METHODS AND RESULTS: Two short chain fructans - oligofructose (DP 2-20) and inulin (DP 3-60) - were administered to the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) at 2.5 g day(-1).
  • The influence of fructan addition towards fermentation activity and microbial community composition from the different SHIME colon compartments were evaluated.
  • Both fructans exerted prebiotic effects with significantly higher butyrate and propionate production and stimulation of lactic acid-producing bacteria.
  • Compared with oligofructose, it was noted that it took more time before significant effects from inulin addition were observed.
  • Yet, the higher short-chain fatty acid production and lower proteolytic activity showed that the prebiotic effects from inulin were more pronounced than oligofructose.
  • Also, the bifidogenic effects from inulin vs oligofructose were higher in the distal colon compartments and this effect was prolonged in the distal colon once the addition was stopped.
  • CONCLUSIONS: Inulin has more pronounced prebiotic effects than oligofructose towards both fermentation activity and bacterial community composition in the SHIME model.
  • SIGNIFICANCE AND IMPACT OF THE STUDY: Its slower fermentation rate and higher prebiotic potency makes inulin a more interesting compound than oligofructose to beneficially influence the microbial community from both the proximal and distal colon regions.
  • [MeSH-major] Colon / microbiology. Dietary Fiber / pharmacology. Fructans / pharmacology. Probiotics
  • [MeSH-minor] Bifidobacterium / genetics. Bifidobacterium / physiology. Chicory. Colony Count, Microbial. DNA Fingerprinting. Fatty Acids, Volatile / analysis. Fermentation. Humans. Inulin / chemistry. Inulin / pharmacology. Oligosaccharides / chemistry. Oligosaccharides / pharmacology. Polymers

  • MedlinePlus Health Information. consumer health - Dietary Fiber.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17241351.001).
  • [ISSN] 1364-5072
  • [Journal-full-title] Journal of applied microbiology
  • [ISO-abbreviation] J. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Fatty Acids, Volatile; 0 / Fructans; 0 / Oligosaccharides; 0 / Polymers; 0 / oligofructose; 9005-80-5 / Inulin
  •  go-up   go-down


88. Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA: Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol; 2006 Jan;13(1):52-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A subset of these represents biologically aggressive disease, yet prognostic features for identifying this high-risk category are lacking.
  • [MeSH-major] Breast Neoplasms / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adult. Aged. Axilla. Chi-Square Distribution. Female. Humans. Lymph Node Excision. Lymphatic Metastasis. Mastectomy, Segmental. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16372155.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Langsenlehner T, Renner W, Yazdani-Biuki B, Langsenlehner U: Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat; 2008 Feb;107(3):459-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Methylenetetrahydrofolate Reductase (NADPH2) / genetics. Polymorphism, Genetic

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Breast Cancer Res Treat. 2007 Dec;106(2):263-71 [17260091.001]
  • (PMID = 17453338.001).
  • [ISSN] 0167-6806
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 1.5.1.20 / Methylenetetrahydrofolate Reductase (NADPH2)
  •  go-up   go-down


90. López AM, Graham AR, Barker GP, Richter LC, Krupinski EA, Lian F, Grasso LL, Miller A, Kreykes LN, Henderson JT, Bhattacharyya AK, Weinstein RS: Virtual slide telepathology enables an innovative telehealth rapid breast care clinic. Semin Diagn Pathol; 2009 Nov;26(4):177-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Virtual slide telepathology enables an innovative telehealth rapid breast care clinic.
  • An innovative telemedicine-enabled rapid breast care service is described that bundles telemammography, telepathology, and teleoncology services into a single day process.
  • The service is called the UltraClinics Process.
  • Since the core services are at four different physical locations a challenge has been to obtain STAT second opinion readouts on newly diagnosed breast cancer cases.
  • In order to provide same day QA re-review of breast surgical pathology cases, a DMetrix DX-40 ultrarapid virtual slide scanner (DMetrix, Inc., Tucson, AZ) was installed at the participating laboratory.
  • Glass slides of breast cancer and breast hyperplasia cases were scanned the same day the slides were produced by the University Physicians Healthcare Hospital histology laboratory.
  • Virtual slide telepathology was used for STAT quality assurance readouts at University Medical Center, 6 miles away.
  • There was complete concurrence with the primary diagnosis in 139 (90.3%) of cases.
  • There were 4 (2.3%) major discrepancies, which would have resulted in a different therapy and 3 (1.9%) minor discrepancies.
  • Three cases (1.9%) were deferred for immunohistochemistry.
  • In 2 cases (1.3%), the case was deferred for examination of the glass slides by the reviewing pathologists at University Medical Center.
  • We conclude that the virtual slide telepathology QA program found a small number of significant diagnostic discrepancies.
  • The virtual slide telepathology program service increased the job satisfaction of subspecialty pathologists without special training in breast pathology, assigned to cover the general surgical pathology service at a small satellite university hospital.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ReprintOf] Hum Pathol. 2009 Aug;40(8):1082-91 [19552938.001]
  • (PMID = 20069779.001).
  • [ISSN] 0740-2570
  • [Journal-full-title] Seminars in diagnostic pathology
  • [ISO-abbreviation] Semin Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Egervari K, Toth J, Nemes Z, Szollosi Z: An alternative and reliable real-time quantitative PCR method to determine HER2/neu amplification in breast cancer. Appl Immunohistochem Mol Morphol; 2009 May;17(3):247-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ways of measuring the copy number of the HER-2/neu gene in tumor cells comprise in situ hybridization techniques and real-time polymerase chain reaction (PCR).

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19098680.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gastrins; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


92. Górski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbański K, Mituś J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Tołoczko-Grabarek A, Medrek K, Masojć B, Mierzejewski M, Kowalska E, Narod SA, Lubiński J: Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat; 2005 Jul;92(1):19-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / genetics. Cell Cycle Proteins / genetics. Genes, BRCA1. Nuclear Proteins / genetics. Protein-Serine-Threonine Kinases / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Alleles. Checkpoint Kinase 2. Female. Genetic Predisposition to Disease. Humans. Middle Aged. Poland / epidemiology. Prevalence. Risk. Risk Assessment

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15980987.001).
  • [ISSN] 0167-6806
  • [Journal-full-title] Breast cancer research and treatment
  • [ISO-abbreviation] Breast Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / NBN protein, human; 0 / Nuclear Proteins; EC 2.7.1.11 / Checkpoint Kinase 2; EC 2.7.11.1 / CHEK2 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


93. Desgranges C, Delhommelle J: Molecular simulation of the crystallization of aluminum from the supercooled liquid. J Chem Phys; 2007 Oct 14;127(14):144509
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular simulation of the crystallization of aluminum from the supercooled liquid.
  • We report hybrid Monte Carlo molecular simulation results on the crystallization of aluminum from the supercooled liquid.
  • We simulate the entire crystallization process at P=1 atm and at temperatures 20% and 15% below the melting temperature.
  • We demonstrate that crystallization takes place according to the same mechanism for the two degrees of supercooling considered in this work.
  • We show that both nucleation and growth proceed into a random mixing of the hexagonal close packed structure and of the face centered cubic (fcc) phase, with a predominance of the stable fcc form.
  • The concentration of icosahedral (Ih)-like atoms in the supercooled liquid is found to remain constant throughout nucleation and growth, showing that Ih-like atoms do not play an active role in the crystallization process.
  • We also find that the crystallization mechanism of aluminum differs from that observed for simple fluids.
  • While nucleation of simple fluids first proceeds into the metastable body centered cubic (bcc) phase, the fraction of bcc-like atoms in aluminum crystallites always remains very low.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17935411.001).
  • [ISSN] 0021-9606
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Karen JK, Gareau DS, Dusza SW, Tudisco M, Rajadhyaksha M, Nehal KS: Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy. Br J Dermatol; 2009 Jun;160(6):1242-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.
  • Nuclear and cellular morphology is observed in thin optical sections, similar to that in conventional histology.
  • OBJECTIVES: To evaluate the sensitivity and specificity of ex vivo real-time imaging with fluorescence confocal mosaicing microscopy, using acridine orange, for the detection of residual basal cell carcinoma (BCC) in Mohs fresh tissue excisions.
  • Very good correlation was observed between confocal mosaics and matched Mohs frozen sections for benign and malignant skin structures, overall tumour burden and location, and identification of all major histological subtypes of BCC.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Mohs Surgery / methods. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surgery. 2000 Dec;128(6):1088-1100; discussion 1100-1 [11114647.001]
  • [Cites] J Microsc. 2009 Jan;233(1):149-59 [19196421.001]
  • [Cites] Arch Dermatol. 2004 Jun;140(6):736-42 [15210467.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2004 Aug;130(8):923-8 [15313861.001]
  • [Cites] J Cell Biol. 1985 Apr;100(4):1309-23 [3920227.001]
  • [Cites] Dermatol Surg. 2004 Dec;30(12 Pt 1):1470-8 [15606734.001]
  • [Cites] J Biomed Opt. 2005 May-Jun;10(3):034009 [16229653.001]
  • [Cites] Br J Dermatol. 2006 Feb;154(2):305-9 [16433801.001]
  • [Cites] Opt Lett. 2006 Apr 1;31(7):942-4 [16599219.001]
  • [Cites] J Am Acad Dermatol. 2006 Sep;55(3):408-12 [16908344.001]
  • [Cites] Opt Lett. 2006 Sep 15;31(18):2756-8 [16936882.001]
  • [Cites] J Biomed Opt. 2007 Jan-Feb;12(1):014005 [17343480.001]
  • [Cites] Appl Opt. 2007 Apr 1;46(10):1843-51 [17356629.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):034004 [17614712.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):034027 [17614735.001]
  • [Cites] Lasers Surg Med. 2007 Oct;39(9):696-705 [17960751.001]
  • [Cites] J Biomed Opt. 2007 Sep-Oct;12(5):051901 [17994884.001]
  • [Cites] J Invest Dermatol. 2008 May;128(5):1248-55 [17989735.001]
  • [Cites] J Biomed Opt. 2008 Mar-Apr;13(2):024013 [18465976.001]
  • [Cites] Br J Dermatol. 2008 Jul;159(1):152-61 [18460029.001]
  • [Cites] J Biomed Opt. 2008 Jul-Aug;13(4):044016 [19021344.001]
  • [Cites] J Biomed Opt. 2008 Sep-Oct;13(5):054001 [19021381.001]
  • [Cites] J Invest Dermatol. 2001 Nov;117(5):1137-43 [11710924.001]
  • (PMID = 19416248.001).
  • [ISSN] 1365-2133
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA008748; United States / NIBIB NIH HHS / EB / R01 EB002715; United States / NIBIB NIH HHS / EB / R01 EB002715-05; United States / NIBIB NIH HHS / EB / R01EB002715
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS95359; NLM/ PMC2693082
  •  go-up   go-down


95. Fullen DR, Garrisi AJ, Sanders D, Thomas D: Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. J Cutan Pathol; 2008 Nov;35 Suppl 2:28-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Tissue microarrays of cutaneous epithelial neoplasms, mesenchymal neoplasms, DM and malignant peripheral nerve sheath tumors (MPNST) were stained with S100A6 antibody.
  • RESULTS: Eleven basal cell carcinomas (BCC) failed to express S100A6, whereas all 10 squamous cell carcinomas (SCC) expressed S100A6.
  • Malignant spindle cell tumors, with the exception of 13 of 30 MPNST, had a high incidence of S100A6 positivity.
  • [MeSH-major] Biomarkers, Tumor / analysis. Cell Cycle Proteins / biosynthesis. S100 Proteins / biosynthesis. Skin Neoplasms / diagnosis. Skin Neoplasms / metabolism
  • [MeSH-minor] Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / metabolism. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / metabolism. Diagnosis, Differential. Humans. Melanoma / diagnosis. Melanoma / metabolism. Neoplasms, Adnexal and Skin Appendage / diagnosis. Neoplasms, Adnexal and Skin Appendage / metabolism. Nerve Sheath Neoplasms / diagnosis. Nerve Sheath Neoplasms / metabolism. Tissue Array Analysis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18201235.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / S100 Proteins; 105504-00-5 / S100A6 protein, human
  •  go-up   go-down


96. Han J, Cox DG, Colditz GA, Hunter DJ: The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women. Mol Carcinog; 2006 Sep;45(9):694-700
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The p53 gene is involved in the control of cell-cycle arrest and apoptosis.
  • We evaluated the association of the Arg72Pro polymorphism with skin cancer risk among Caucasians in a nested case-control study within the Nurses' Health Study (NHS) (219 melanoma, 286 squamous cell carcinoma (SCC), and 300 basal cell carcinoma (BCC) and 874 controls).
  • [MeSH-major] Codon / genetics. Genetic Predisposition to Disease. Skin Neoplasms / genetics. Sunburn / genetics. Tumor Suppressor Protein p53 / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Sun Exposure.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16739124.001).
  • [ISSN] 0899-1987
  • [Journal-full-title] Molecular carcinogenesis
  • [ISO-abbreviation] Mol. Carcinog.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA09001-27; United States / NCI NIH HHS / CA / CA113100; United States / NCI NIH HHS / CA / CA87969
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Codon; 0 / Tumor Suppressor Protein p53; 94ZLA3W45F / Arginine
  •  go-up   go-down


97. Tsai TM, Wu YH, Yang KC, Yang CY, Tsai TH, Chan JY: Sebaceous carcinoma associated with seborrheic keratosis. J Cutan Med Surg; 2010 Sep-Oct;14(5):240-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The association of a seborrheic keratosis with other common cutaneous neoplasms such as basal cell carcinoma and Bowen disease has been reported, but the association between a seborrheic keratotis and a malignant neoplasm with sebaceous differentiation is very unusual.
  • OBJECTIVE: We present a case of two contiguous neoplasms, a seborrheic keratosis and a sebaceous carcinoma, and discuss the possibility of malignant change in a seborrheic keratosis as an explanation for the findings.
  • METHODS AND RESULTS: A 57-year-old man presented with an asymptomatic tumor on the skin of his abdomen that was composed of two separate but contiguous lesions.
  • CONCLUSION: Although the association is likely to be a coincidence and probably represents a collision tumor, the possibility that the sebaceous carcinoma represents malignant degeneration of the seborrheic keratosis cannot be entirely excluded.
  • [MeSH-major] Keratosis, Seborrheic / pathology. Sebaceous Gland Neoplasms / pathology

  • Genetic Alliance. consumer health - Keratosis, seborrheic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20868621.001).
  • [ISSN] 1203-4754
  • [Journal-full-title] Journal of cutaneous medicine and surgery
  • [ISO-abbreviation] J Cutan Med Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


98. Sharma R, Tripathi M, Panwar P, Chuttani K, Jaimini A, Maitra S, Chopra MK, Sawroop K, Shukla G, Mondal A, Mishra A: 99mTc-methionine scintimammography in the evaluation of breast cancer. Nucl Med Commun; 2009 May;30(5):338-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The diagnostic utility of a C-methionine scan has been established in breast cancer.
  • RESULTS: The histopathological findings were malignant in 33 (70%) and benign in 14 (30%) cases.
  • True-negative findings were found in 13 out of 14 patients having benign breast lesions.
  • [MeSH-major] Breast Neoplasms / radionuclide imaging. Methionine. Radiopharmaceuticals

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. (L)-Methionine .
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19282793.001).
  • [ISSN] 0143-3636
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carbon Radioisotopes; 0 / Radiopharmaceuticals; 7440-26-8 / Technetium; AE28F7PNPL / Methionine
  •  go-up   go-down


99. Wakai K, Kojima M, Nishio K, Suzuki S, Niwa Y, Lin Y, Kondo T, Yatsuya H, Tamakoshi K, Yamamoto A, Tokudome S, Toyoshima H, Tamakoshi A, JACC Study Group: Psychological attitudes and risk of breast cancer in Japan: a prospective study. Cancer Causes Control; 2007 Apr;18(3):259-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Breast Neoplasms / psychology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17334812.001).
  • [ISSN] 0957-5243
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


100. Arias CR, Abernathy JW, Liu Z: Combined use of 16S ribosomal DNA and automated ribosomal intergenic spacer analysis to study the bacterial community in catfish ponds. Lett Appl Microbiol; 2006 Sep;43(3):287-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined use of 16S ribosomal DNA and automated ribosomal intergenic spacer analysis to study the bacterial community in catfish ponds.
  • AIMS: To apply culture-independent techniques to explore the bacterial community composition in catfish pond water.
  • METHODS AND RESULTS: 16S rDNA libraries were constructed and sequenced from 15 pond water samples.
  • Automated ribosomal intergenic spacer analysis (ARISA) was used to fingerprint each bacterial community.
  • A broad diversity in bacterial species composition was found by 16S rDNA analysis.
  • Alphaproteobacteria was the most represented class in all ponds, followed by Gammaproteobacteria and Gram-positive high G + C content bacteria.
  • Uniqueness of bacterial communities from each individual pond was confirmed by ARISA.
  • Catfish pathogens were detected sporadically.
  • CONCLUSIONS: Bacterial communities in a catfish aquaculture setting can vary from pond to pond at one given point.
  • No correlation could be made between bacteria composition and fish strain or between bacterial profile and the presence of catfish pathogens in a particular pond.
  • SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report showing the composition of bacterial communities in catfish ponds.
  • Fish health specialists and catfish aquaculture managers should be aware of the wide differences in bacterial communities between ponds and include this variable in fish husbandry practices.
  • [MeSH-major] Bacteria / classification. Bacteria / isolation & purification. Catfishes / microbiology. DNA, Ribosomal Spacer / genetics
  • [MeSH-minor] Animals. Gene Library. RNA, Ribosomal, 16S / genetics. Ribotyping / instrumentation

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16910933.001).
  • [ISSN] 0266-8254
  • [Journal-full-title] Letters in applied microbiology
  • [ISO-abbreviation] Lett. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Ribosomal Spacer; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down






Advertisement